<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02132754</url>
  </required_header>
  <id_info>
    <org_study_id>4166-001</org_study_id>
    <secondary_id>MK-4166-001</secondary_id>
    <nct_id>NCT02132754</nct_id>
  </id_info>
  <brief_title>Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)</brief_title>
  <official_title>Phase 1 Trial of Single Agent MK-4166 and MK-4166 in Combination With Pembrolizumab in Subjects With Advanced Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is planned to be a 5-part dose-escalation study to determine the safety and tolerability&#xD;
      of MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy, and to establish&#xD;
      the maximum tolerated dose (MTD) or maximum administered dose (MAD) of MK-4166 and MK-4166&#xD;
      plus pembrolizumab by defining dose-limiting toxicities (DLTs) in participants with advanced&#xD;
      solid tumors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Part A, MK-4166 doses will be escalated quickly in successive cohorts and based on safety&#xD;
      events may progress to Part B, in which the preliminary MTD will be identified. Based on&#xD;
      safety events the study may progress to Part C in which the MTD will be confirmed. In Part D,&#xD;
      participants will receive escalating doses of MK-4166 plus a fixed dose of pembrolizumab&#xD;
      (MK-3475) 200 mg to determine the MTD for MK-4166 in combination with pembrolizumab. Based on&#xD;
      safety events in Part D, the study may progress to Part E in which the MTD for MK-4166 in&#xD;
      combination with pembrolizumab will be confirmed.&#xD;
&#xD;
      With Amendments 05/06, the dose confirmation Part C will be removed and the dose confirmation&#xD;
      Part E (combination of MK-4166 and pembrolizumab) will be limited to participants with&#xD;
      advanced malignant melanoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 27, 2014</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Experiencing Dose-Limiting Toxicities (DLTs)</measure>
    <time_frame>Cycle 1 (up to 21 days)</time_frame>
    <description>DLT's were assessed during the first cycle (21 days) for each dose level and included the following if assessed by the Investigator to be possibly, probably or definitely related to MK-4166 or MK-4166 plus pembrolizumab combination: Grade 4 non-hematologic toxicity; Grade 4 hematologic toxicity lasting ≥7 days, except thrombocytopenia (Grade 4 thrombocytopenia of any duration or Grade 3 thrombocytopenia if associated with bleeding); Grade 3 non-hematologic toxicity lasting &gt;3 days despite optimal supportive care; Grade 3 nausea, vomiting or diarrhea if &gt;3 days despite optimal supportive care; any Grade 3 or Grade 4 non-hematologic laboratory abnormality if medical intervention is required or if leading to hospitalization or if persisting for &gt;1 week; febrile neutropenia Grade 3 or Grade 4; any drug-related AE which caused participant to discontinue treatment during Cycle 1; Grade 5 toxicity; any treatment-related toxicity which caused a &gt;2 week delay in initiation of Cycle 2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Experiencing Adverse Events (AEs)</measure>
    <time_frame>From first dose up to 90 days post last dose (up to 27 months)</time_frame>
    <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants experiencing an AE was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Discontinuing Study Treatment Due to AEs</measure>
    <time_frame>Up to approximately 24 months</time_frame>
    <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants discontinuing study treatment due to AEs was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum Concentration (Cmax) of MK-4166 Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Cmax. Cmax was defined as the maximum concentration of MK-4166 reached. MK-4166 Cmax was reported by dose cohort. Per protocol, percent geometric coefficient of variation (%GCV) values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Concentration (Tmax) of MK-4166 Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Tmax. Tmax was defined as time to the maximum concentration of MK-4166 reached. MK-4166 Tmax was reported by dose cohort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Terminal Half-Life (t ½) of MK-4166 Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 t½. t½ was defined as the time required to divide the MK-4166 plasma concentration by two after reaching pseudo-equilibrium, following a single dose of MK-4166. MK-4166 t½ was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Day 2. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of MK-4166 from time zero to 21 hours after dosing. MK-4166 AUC0-21 was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-last. AUC0-last was defined as the area under the concentration-time curve of MK-4166 from time zero to the last quantifiable sample. MK-4166 AUC0-last was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to Infinity (AUC 0-inf) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of MK-4166 from time zero to infinity. MK-4166 AUC0-inf was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Clearance (CL) of MK-4166 Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 CL. CL was defined as the volume of plasma from which MK-4166 is eliminated per unit time following IV MK-4166 administration. MK-4166 CL was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Volume of Distribution (V) of MK-4166 Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered MK-4166 at the same concentration that it is observed in the blood plasma. MK-4166 V was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Concentration (Cmax) of Pembrolizumab Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Cmax. Cmax was defined as the maximum concentration of pembrolizumab reached. Pembrolizumab Cmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Concentration (Tmax) of Pembrolizumab Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Tmax. Tmax was defined as time to the maximum concentration of pembrolizumab reached. Pembrolizumab Tmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Terminal Half-Life (t ½) of Pembrolizumab Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab t½. t½ was defined as the time required to divide the pembrolizumab plasma concentration by two after reaching pseudo-equilibrium, following a single dose of pembrolizumab. Pembrolizumab t½ was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Day 2. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of pembrolizumab from time zero to 21 hours after dosing. Pembrolizumab AUC0-21 was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-last. AUC0-last was defined as the area under the concentration-time curve of pembrolizumab from time zero to the last quantifiable sample. Pembrolizumab AUC0-last was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to Infinity (AUC 0-inf) Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of pembrolizumab from time zero to infinity. Pembrolizumab AUC0-inf was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Clearance (CL) of Pembrolizumab Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab CL. CL was defined as the volume of plasma from which pembrolizumab is eliminated per unit time following IV pembrolizumab administration. Pembrolizumab CL was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Volume of Distribution (V) of Pembrolizumab Over Time</measure>
    <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
    <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered pembrolizumab at the same concentration that it is observed in the blood plasma. Pembrolizumab V was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein (GITR) Receptor Availability Following MK-4166 Administration</measure>
    <time_frame>Cycle 1 Day 1: at end of infusion (up to 10 minutes), 2 hours post-infusion, Cycle 1 Days 2, 3, 5, 8, 15, Cycle 2 Day 1 pre-dose. Each cycle was 21 days.</time_frame>
    <description>GITR protein receptor is internalized upon binding by MK-4166. To evaluate GITR target engagement, a GITR receptor availability assay was developed to assess the availability of cell surface GITR following administration of MK-4166. GITR was detected on CD4+CD25+ and CD4+CD95+ T-cell sub-populations in peripheral blood using flow cytometry. GITR receptor availability on representative CD4+ CD25+ T cell subsets following MK-4166 administration was reported over time for each dose cohort.</description>
  </secondary_outcome>
  <number_of_arms>34</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>Solid Tumor</condition>
  <arm_group>
    <arm_group_label>MK-4166 0.0015 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 0.0045 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 0.014 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 0.04 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 0.12 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 0.37 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 1.1 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 3.3 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 10 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 30 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 42 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 59 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 82 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 120 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 170 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 240 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 340 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 480 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 670 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 900 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 1.1 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 3.3 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 10 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 30 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 42 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 59 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 82 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 120 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 170 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 240 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 340 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 480 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 670 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MK-4166 900 mg + Pembro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MK-4166</intervention_name>
    <arm_group_label>MK-4166 0.0015 mg</arm_group_label>
    <arm_group_label>MK-4166 0.0045 mg</arm_group_label>
    <arm_group_label>MK-4166 0.014 mg</arm_group_label>
    <arm_group_label>MK-4166 0.04 mg</arm_group_label>
    <arm_group_label>MK-4166 0.12 mg</arm_group_label>
    <arm_group_label>MK-4166 0.37 mg</arm_group_label>
    <arm_group_label>MK-4166 1.1 mg</arm_group_label>
    <arm_group_label>MK-4166 1.1 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 10 mg</arm_group_label>
    <arm_group_label>MK-4166 10 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 120 mg</arm_group_label>
    <arm_group_label>MK-4166 120 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 170 mg</arm_group_label>
    <arm_group_label>MK-4166 170 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 240 mg</arm_group_label>
    <arm_group_label>MK-4166 240 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 3.3 mg</arm_group_label>
    <arm_group_label>MK-4166 3.3 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 30 mg</arm_group_label>
    <arm_group_label>MK-4166 30 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 340 mg</arm_group_label>
    <arm_group_label>MK-4166 340 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 42 mg</arm_group_label>
    <arm_group_label>MK-4166 42 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 480 mg</arm_group_label>
    <arm_group_label>MK-4166 480 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 59 mg</arm_group_label>
    <arm_group_label>MK-4166 59 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 670 mg</arm_group_label>
    <arm_group_label>MK-4166 670 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 82 mg</arm_group_label>
    <arm_group_label>MK-4166 82 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 900 mg</arm_group_label>
    <arm_group_label>MK-4166 900 mg + Pembro</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Pembrolizumab</intervention_name>
    <arm_group_label>MK-4166 1.1 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 10 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 120 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 170 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 240 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 3.3 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 30 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 340 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 42 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 480 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 59 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 670 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 82 mg + Pembro</arm_group_label>
    <arm_group_label>MK-4166 900 mg + Pembro</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Has a histologically- or cytologically-confirmed metastatic solid tumor for which&#xD;
             there is no available therapy which may convey clinical benefit. Part E: Has advanced&#xD;
             malignant melanoma.&#xD;
&#xD;
          -  Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) version&#xD;
             1.1&#xD;
&#xD;
          -  Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG)&#xD;
             Performance Scale&#xD;
&#xD;
          -  Adequate organ function&#xD;
&#xD;
          -  Female participants of childbearing potential must have a negative urine or serum&#xD;
             pregnancy test and must be surgically sterile or willing to use 2 methods of birth&#xD;
             control or abstain from heterosexual activity for the course of the study through 120&#xD;
             days after last dose of study drug&#xD;
&#xD;
          -  Male participants must agree to use an adequate method of contraception during sexual&#xD;
             contact with females of childbearing potential starting with the first dose of study&#xD;
             drug through 180 days after the last dose of study drug&#xD;
&#xD;
          -  Submit an evaluable tumor sample for analysis.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Chemotherapy, radiation, or biological cancer therapy within 4 weeks prior to the&#xD;
             first dose of study drug, or who has not recovered to Common Terminology Criteria for&#xD;
             Adverse Events (CTCAE) Grade 1 or better from the adverse events due to cancer&#xD;
             therapeutics administered more than 4 weeks earlier&#xD;
&#xD;
          -  Currently participating or has participated in a study of an investigational agent or&#xD;
             using an investigational device within 28 days of administration of MK-4166&#xD;
&#xD;
          -  Expected to require any other form of antineoplastic therapy while on study&#xD;
&#xD;
          -  On chronic systemic steroid therapy in excess of replacement doses, or on any other&#xD;
             form of immunosuppressive medication&#xD;
&#xD;
          -  History of a malignancy for which potentially curative treatment has been completed,&#xD;
             with no evidence of malignancy for 5 years excepting successful definitive resection&#xD;
             of basal cell carcinoma of the skin, superficial bladder cancer, or in situ cervical&#xD;
             cancer&#xD;
&#xD;
          -  Known active central nervous system (CNS) metastases and/or carcinomatous meningitis&#xD;
&#xD;
          -  Severe hypersensitivity reaction to treatment with another monoclonal antibody&#xD;
&#xD;
          -  Active autoimmune disease or a documented history of autoimmune disease, except&#xD;
             vitiligo or resolved childhood asthma/atopy&#xD;
&#xD;
          -  Active infection requiring therapy&#xD;
&#xD;
          -  Current pneumonitis, or a history of (non-infectious) pneumonitis that required&#xD;
             steroids&#xD;
&#xD;
          -  Prior stem cell or bone marrow transplant&#xD;
&#xD;
          -  Positive for human immunodeficiency virus (HIV), Hepatitis B, or Hepatitis C&#xD;
&#xD;
          -  Known psychiatric or substance abuse disorders that would interfere with cooperation&#xD;
             with the requirements of the trial&#xD;
&#xD;
          -  Regular user (including &quot;recreational use&quot;) of any illicit drugs or recent history&#xD;
             (within the last year) of substance abuse (including alcohol)&#xD;
&#xD;
          -  Symptomatic ascites or pleural effusion&#xD;
&#xD;
          -  Pregnant, breastfeeding, or expecting to conceive or father children within the&#xD;
             projected duration of the study&#xD;
&#xD;
          -  Clinically significant heart disease&#xD;
&#xD;
          -  Major surgery in the past 16 weeks&#xD;
&#xD;
          -  Received a live vaccine within 30 days prior to first dose of study drug&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>Australia</country>
    <country>Israel</country>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Papadopoulos KP, Autio K, Golan T, Dobrenkov K, Chartash E, Chen Q, Wnek R, Long GV. Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 Apr 1;27(7):1904-1911. doi: 10.1158/1078-0432.CCR-20-2886. Epub 2020 Dec 21.</citation>
    <PMID>33355238</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>May 5, 2014</study_first_submitted>
  <study_first_submitted_qc>May 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2014</study_first_posted>
  <results_first_submitted>July 13, 2020</results_first_submitted>
  <results_first_submitted_qc>July 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 31, 2020</results_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pembrolizumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT02132754/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of 116 participants that were non-randomly allocated to treatment, 113 participants received treatment and were evaluable for all analyses.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>MK-4166 0.0015 mg</title>
          <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P2">
          <title>MK-4166 0.0045 mg</title>
          <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P3">
          <title>MK-4166 0.014 mg</title>
          <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P4">
          <title>MK-4166 0.04 mg</title>
          <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P5">
          <title>MK-4166 0.12 mg</title>
          <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P6">
          <title>MK-4166 0.37 mg</title>
          <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P7">
          <title>MK-4166 1.1 mg</title>
          <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P8">
          <title>MK-4166 3.3 mg</title>
          <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P9">
          <title>MK-4166 10 mg</title>
          <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P10">
          <title>MK-4166 30 mg</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P11">
          <title>MK-4166 42 mg</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P12">
          <title>MK-4166 59 mg</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P13">
          <title>MK-4166 82 mg</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P14">
          <title>MK-4166 120 mg</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P15">
          <title>MK-4166 170 mg</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P16">
          <title>MK-4166 240 mg</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P17">
          <title>MK-4166 340 mg</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P18">
          <title>MK-4166 480 mg</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P19">
          <title>MK-4166 670 mg</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P20">
          <title>MK-4166 900 mg</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="P21">
          <title>MK-4166 1.1 mg + Pembro</title>
          <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P22">
          <title>MK-4166 3.3 mg + Pembro</title>
          <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P23">
          <title>MK-4166 10 mg + Pembro</title>
          <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P24">
          <title>MK-4166 30 mg + Pembro</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P25">
          <title>MK-4166 42 mg + Pembro</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P26">
          <title>MK-4166 59 mg + Pembro</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P27">
          <title>MK-4166 82 mg + Pembro</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P28">
          <title>MK-4166 120 mg + Pembro</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P29">
          <title>MK-4166 170 mg + Pembro</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P30">
          <title>MK-4166 240 mg + Pembro</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P31">
          <title>MK-4166 340 mg + Pembro</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P32">
          <title>MK-4166 480 mg + Pembro</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P33">
          <title>MK-4166 670 mg + Pembro</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="P34">
          <title>MK-4166 900 mg + Pembro</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="4"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="4"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="4"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="3"/>
                <participants group_id="P24" count="3"/>
                <participants group_id="P25" count="3"/>
                <participants group_id="P26" count="3"/>
                <participants group_id="P27" count="4"/>
                <participants group_id="P28" count="3"/>
                <participants group_id="P29" count="3"/>
                <participants group_id="P30" count="3"/>
                <participants group_id="P31" count="3"/>
                <participants group_id="P32" count="3"/>
                <participants group_id="P33" count="4"/>
                <participants group_id="P34" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="3"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="4"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="3"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="4"/>
                <participants group_id="P23" count="3"/>
                <participants group_id="P24" count="3"/>
                <participants group_id="P25" count="3"/>
                <participants group_id="P26" count="3"/>
                <participants group_id="P27" count="4"/>
                <participants group_id="P28" count="3"/>
                <participants group_id="P29" count="3"/>
                <participants group_id="P30" count="3"/>
                <participants group_id="P31" count="3"/>
                <participants group_id="P32" count="3"/>
                <participants group_id="P33" count="4"/>
                <participants group_id="P34" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="4"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="4"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="4"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="3"/>
                <participants group_id="P24" count="3"/>
                <participants group_id="P25" count="3"/>
                <participants group_id="P26" count="3"/>
                <participants group_id="P27" count="4"/>
                <participants group_id="P28" count="3"/>
                <participants group_id="P29" count="3"/>
                <participants group_id="P30" count="3"/>
                <participants group_id="P31" count="3"/>
                <participants group_id="P32" count="3"/>
                <participants group_id="P33" count="4"/>
                <participants group_id="P34" count="23"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="1"/>
                <participants group_id="P27" count="1"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="1"/>
                <participants group_id="P34" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Clinical Progression</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="1"/>
                <participants group_id="P26" count="1"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="1"/>
                <participants group_id="P29" count="1"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="1"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Excluded Medication</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="1"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="1"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive Disease</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="2"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="3"/>
                <participants group_id="P23" count="2"/>
                <participants group_id="P24" count="3"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="1"/>
                <participants group_id="P27" count="2"/>
                <participants group_id="P28" count="1"/>
                <participants group_id="P29" count="2"/>
                <participants group_id="P30" count="3"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="1"/>
                <participants group_id="P33" count="3"/>
                <participants group_id="P34" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Screen Failure</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transferred to Extension Study</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="1"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="1"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="1"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MK-4166 0.0015 mg</title>
          <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B2">
          <title>MK-4166 0.0045 mg</title>
          <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B3">
          <title>MK-4166 0.014 mg</title>
          <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B4">
          <title>MK-4166 0.04 mg</title>
          <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B5">
          <title>MK-4166 0.12 mg</title>
          <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B6">
          <title>MK-4166 0.37 mg</title>
          <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B7">
          <title>MK-4166 1.1 mg</title>
          <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B8">
          <title>MK-4166 3.3 mg</title>
          <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B9">
          <title>MK-4166 10 mg</title>
          <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B10">
          <title>MK-4166 30 mg</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B11">
          <title>MK-4166 42 mg</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B12">
          <title>MK-4166 59 mg</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B13">
          <title>MK-4166 82 mg</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B14">
          <title>MK-4166 120 mg</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B15">
          <title>MK-4166 170 mg</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B16">
          <title>MK-4166 240 mg</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B17">
          <title>MK-4166 340 mg</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B18">
          <title>MK-4166 480 mg</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B19">
          <title>MK-4166 670 mg</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B20">
          <title>MK-4166 900 mg</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="B21">
          <title>MK-4166 1.1 mg + Pembro</title>
          <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B22">
          <title>MK-4166 3.3 mg + Pembro</title>
          <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B23">
          <title>MK-4166 10 mg + Pembro</title>
          <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B24">
          <title>MK-4166 30 mg + Pembro</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B25">
          <title>MK-4166 42 mg + Pembro</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B26">
          <title>MK-4166 59 mg + Pembro</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B27">
          <title>MK-4166 82 mg + Pembro</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B28">
          <title>MK-4166 120 mg + Pembro</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B29">
          <title>MK-4166 170 mg + Pembro</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B30">
          <title>MK-4166 240 mg + Pembro</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B31">
          <title>MK-4166 340 mg + Pembro</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B32">
          <title>MK-4166 480 mg + Pembro</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B33">
          <title>MK-4166 670 mg + Pembro</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B34">
          <title>MK-4166 900 mg + Pembro</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="B35">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="1"/>
            <count group_id="B4" value="1"/>
            <count group_id="B5" value="1"/>
            <count group_id="B6" value="1"/>
            <count group_id="B7" value="1"/>
            <count group_id="B8" value="1"/>
            <count group_id="B9" value="1"/>
            <count group_id="B10" value="6"/>
            <count group_id="B11" value="3"/>
            <count group_id="B12" value="3"/>
            <count group_id="B13" value="4"/>
            <count group_id="B14" value="3"/>
            <count group_id="B15" value="3"/>
            <count group_id="B16" value="5"/>
            <count group_id="B17" value="4"/>
            <count group_id="B18" value="3"/>
            <count group_id="B19" value="3"/>
            <count group_id="B20" value="4"/>
            <count group_id="B21" value="3"/>
            <count group_id="B22" value="5"/>
            <count group_id="B23" value="3"/>
            <count group_id="B24" value="3"/>
            <count group_id="B25" value="3"/>
            <count group_id="B26" value="3"/>
            <count group_id="B27" value="4"/>
            <count group_id="B28" value="3"/>
            <count group_id="B29" value="3"/>
            <count group_id="B30" value="3"/>
            <count group_id="B31" value="3"/>
            <count group_id="B32" value="3"/>
            <count group_id="B33" value="4"/>
            <count group_id="B34" value="23"/>
            <count group_id="B35" value="116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.0" spread="0"/>
                    <measurement group_id="B2" value="50.0" spread="0"/>
                    <measurement group_id="B3" value="43.0" spread="0"/>
                    <measurement group_id="B4" value="47.0" spread="0"/>
                    <measurement group_id="B5" value="74.0" spread="0"/>
                    <measurement group_id="B6" value="65.0" spread="0"/>
                    <measurement group_id="B7" value="72.0" spread="0"/>
                    <measurement group_id="B8" value="73.0" spread="0"/>
                    <measurement group_id="B9" value="50.0" spread="0"/>
                    <measurement group_id="B10" value="64.7" spread="9.3"/>
                    <measurement group_id="B11" value="57.3" spread="7.1"/>
                    <measurement group_id="B12" value="54.3" spread="12.6"/>
                    <measurement group_id="B13" value="66.8" spread="22.5"/>
                    <measurement group_id="B14" value="61.7" spread="4.2"/>
                    <measurement group_id="B15" value="62.0" spread="11.8"/>
                    <measurement group_id="B16" value="64.6" spread="11.7"/>
                    <measurement group_id="B17" value="66.0" spread="9.7"/>
                    <measurement group_id="B18" value="66.7" spread="12.1"/>
                    <measurement group_id="B19" value="64.0" spread="12.2"/>
                    <measurement group_id="B20" value="71.8" spread="9.3"/>
                    <measurement group_id="B21" value="60.3" spread="7.0"/>
                    <measurement group_id="B22" value="52.2" spread="17.2"/>
                    <measurement group_id="B23" value="58.0" spread="11.4"/>
                    <measurement group_id="B24" value="48.3" spread="25.5"/>
                    <measurement group_id="B25" value="52.3" spread="3.8"/>
                    <measurement group_id="B26" value="74.0" spread="6.2"/>
                    <measurement group_id="B27" value="49.0" spread="23.2"/>
                    <measurement group_id="B28" value="56.3" spread="11.2"/>
                    <measurement group_id="B29" value="63.0" spread="9.8"/>
                    <measurement group_id="B30" value="49.7" spread="25.1"/>
                    <measurement group_id="B31" value="52.7" spread="17.6"/>
                    <measurement group_id="B32" value="63.3" spread="24.7"/>
                    <measurement group_id="B33" value="60.5" spread="20.5"/>
                    <measurement group_id="B34" value="62.0" spread="15.6"/>
                    <measurement group_id="B35" value="60.4" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="3"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="1"/>
                    <measurement group_id="B23" value="2"/>
                    <measurement group_id="B24" value="2"/>
                    <measurement group_id="B25" value="2"/>
                    <measurement group_id="B26" value="2"/>
                    <measurement group_id="B27" value="3"/>
                    <measurement group_id="B28" value="3"/>
                    <measurement group_id="B29" value="2"/>
                    <measurement group_id="B30" value="2"/>
                    <measurement group_id="B31" value="1"/>
                    <measurement group_id="B32" value="2"/>
                    <measurement group_id="B33" value="1"/>
                    <measurement group_id="B34" value="6"/>
                    <measurement group_id="B35" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="1"/>
                    <measurement group_id="B22" value="4"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="1"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="1"/>
                    <measurement group_id="B30" value="1"/>
                    <measurement group_id="B31" value="2"/>
                    <measurement group_id="B32" value="1"/>
                    <measurement group_id="B33" value="3"/>
                    <measurement group_id="B34" value="17"/>
                    <measurement group_id="B35" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <description>0 participants are reported due to the risk of identification of a person.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="4"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="4"/>
                    <measurement group_id="B21" value="3"/>
                    <measurement group_id="B22" value="5"/>
                    <measurement group_id="B23" value="3"/>
                    <measurement group_id="B24" value="3"/>
                    <measurement group_id="B25" value="3"/>
                    <measurement group_id="B26" value="3"/>
                    <measurement group_id="B27" value="4"/>
                    <measurement group_id="B28" value="3"/>
                    <measurement group_id="B29" value="3"/>
                    <measurement group_id="B30" value="3"/>
                    <measurement group_id="B31" value="3"/>
                    <measurement group_id="B32" value="3"/>
                    <measurement group_id="B33" value="4"/>
                    <measurement group_id="B34" value="23"/>
                    <measurement group_id="B35" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <description>0 participants are reported due to the risk of identification of a person.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="4"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="4"/>
                    <measurement group_id="B21" value="3"/>
                    <measurement group_id="B22" value="5"/>
                    <measurement group_id="B23" value="3"/>
                    <measurement group_id="B24" value="3"/>
                    <measurement group_id="B25" value="3"/>
                    <measurement group_id="B26" value="3"/>
                    <measurement group_id="B27" value="4"/>
                    <measurement group_id="B28" value="3"/>
                    <measurement group_id="B29" value="3"/>
                    <measurement group_id="B30" value="3"/>
                    <measurement group_id="B31" value="3"/>
                    <measurement group_id="B32" value="3"/>
                    <measurement group_id="B33" value="4"/>
                    <measurement group_id="B34" value="23"/>
                    <measurement group_id="B35" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Experiencing Dose-Limiting Toxicities (DLTs)</title>
        <description>DLT's were assessed during the first cycle (21 days) for each dose level and included the following if assessed by the Investigator to be possibly, probably or definitely related to MK-4166 or MK-4166 plus pembrolizumab combination: Grade 4 non-hematologic toxicity; Grade 4 hematologic toxicity lasting ≥7 days, except thrombocytopenia (Grade 4 thrombocytopenia of any duration or Grade 3 thrombocytopenia if associated with bleeding); Grade 3 non-hematologic toxicity lasting &gt;3 days despite optimal supportive care; Grade 3 nausea, vomiting or diarrhea if &gt;3 days despite optimal supportive care; any Grade 3 or Grade 4 non-hematologic laboratory abnormality if medical intervention is required or if leading to hospitalization or if persisting for &gt;1 week; febrile neutropenia Grade 3 or Grade 4; any drug-related AE which caused participant to discontinue treatment during Cycle 1; Grade 5 toxicity; any treatment-related toxicity which caused a &gt;2 week delay in initiation of Cycle 2.</description>
        <time_frame>Cycle 1 (up to 21 days)</time_frame>
        <population>All allocated participants who received at least 1 dose of study treatment and were evaluable for DLTs in Cycle 1.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing Dose-Limiting Toxicities (DLTs)</title>
          <description>DLT's were assessed during the first cycle (21 days) for each dose level and included the following if assessed by the Investigator to be possibly, probably or definitely related to MK-4166 or MK-4166 plus pembrolizumab combination: Grade 4 non-hematologic toxicity; Grade 4 hematologic toxicity lasting ≥7 days, except thrombocytopenia (Grade 4 thrombocytopenia of any duration or Grade 3 thrombocytopenia if associated with bleeding); Grade 3 non-hematologic toxicity lasting &gt;3 days despite optimal supportive care; Grade 3 nausea, vomiting or diarrhea if &gt;3 days despite optimal supportive care; any Grade 3 or Grade 4 non-hematologic laboratory abnormality if medical intervention is required or if leading to hospitalization or if persisting for &gt;1 week; febrile neutropenia Grade 3 or Grade 4; any drug-related AE which caused participant to discontinue treatment during Cycle 1; Grade 5 toxicity; any treatment-related toxicity which caused a &gt;2 week delay in initiation of Cycle 2.</description>
          <population>All allocated participants who received at least 1 dose of study treatment and were evaluable for DLTs in Cycle 1.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                    <measurement group_id="O26" value="0"/>
                    <measurement group_id="O27" value="0"/>
                    <measurement group_id="O28" value="0"/>
                    <measurement group_id="O29" value="0"/>
                    <measurement group_id="O30" value="0"/>
                    <measurement group_id="O31" value="0"/>
                    <measurement group_id="O32" value="0"/>
                    <measurement group_id="O33" value="0"/>
                    <measurement group_id="O34" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Experiencing Adverse Events (AEs)</title>
        <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants experiencing an AE was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
        <time_frame>From first dose up to 90 days post last dose (up to 27 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of study treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 Monotherapy</title>
            <description>Participants received assigned dose of MK-4166 IV on Day 1 of each 21-day cycle, for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 + Pembro Combination Therapy</title>
            <description>Participants received assigned dose of MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O35">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O36">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing Adverse Events (AEs)</title>
          <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants experiencing an AE was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
          <population>All allocated participants who received at least 1 dose of study treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="65"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="1"/>
                <count group_id="O11" value="1"/>
                <count group_id="O12" value="6"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="3"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="4"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="3"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="4"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="3"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="4"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="3"/>
                <count group_id="O34" value="3"/>
                <count group_id="O35" value="4"/>
                <count group_id="O36" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="63"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="4"/>
                    <measurement group_id="O20" value="3"/>
                    <measurement group_id="O21" value="3"/>
                    <measurement group_id="O22" value="3"/>
                    <measurement group_id="O23" value="3"/>
                    <measurement group_id="O24" value="3"/>
                    <measurement group_id="O25" value="3"/>
                    <measurement group_id="O26" value="3"/>
                    <measurement group_id="O27" value="3"/>
                    <measurement group_id="O28" value="3"/>
                    <measurement group_id="O29" value="4"/>
                    <measurement group_id="O30" value="3"/>
                    <measurement group_id="O31" value="3"/>
                    <measurement group_id="O32" value="3"/>
                    <measurement group_id="O33" value="3"/>
                    <measurement group_id="O34" value="3"/>
                    <measurement group_id="O35" value="4"/>
                    <measurement group_id="O36" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Discontinuing Study Treatment Due to AEs</title>
        <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants discontinuing study treatment due to AEs was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
        <time_frame>Up to approximately 24 months</time_frame>
        <population>All allocated participants who received at least 1 dose of study treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 Monotherapy</title>
            <description>Participants received assigned dose of MK-4166 IV on Day 1 of each 21-day cycle, for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 + Pembro Combination Therapy</title>
            <description>Participants received assigned dose of MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O35">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O36">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Discontinuing Study Treatment Due to AEs</title>
          <description>An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE.&#xD;
Per protocol, the number of participants discontinuing study treatment due to AEs was assessed and reported by arm (MK-4166 monotherapy and MK-4166 plus pembrolizumab combination therapy) as well as by dose cohort.</description>
          <population>All allocated participants who received at least 1 dose of study treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="65"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="1"/>
                <count group_id="O11" value="1"/>
                <count group_id="O12" value="6"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="3"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="4"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="3"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="4"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="3"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="4"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="3"/>
                <count group_id="O34" value="3"/>
                <count group_id="O35" value="4"/>
                <count group_id="O36" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                    <measurement group_id="O26" value="0"/>
                    <measurement group_id="O27" value="0"/>
                    <measurement group_id="O28" value="1"/>
                    <measurement group_id="O29" value="1"/>
                    <measurement group_id="O30" value="0"/>
                    <measurement group_id="O31" value="0"/>
                    <measurement group_id="O32" value="0"/>
                    <measurement group_id="O33" value="1"/>
                    <measurement group_id="O34" value="0"/>
                    <measurement group_id="O35" value="1"/>
                    <measurement group_id="O36" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Concentration (Cmax) of MK-4166 Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Cmax. Cmax was defined as the maximum concentration of MK-4166 reached. MK-4166 Cmax was reported by dose cohort. Per protocol, percent geometric coefficient of variation (%GCV) values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable Cmax samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Concentration (Cmax) of MK-4166 Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Cmax. Cmax was defined as the maximum concentration of MK-4166 reached. MK-4166 Cmax was reported by dose cohort. Per protocol, percent geometric coefficient of variation (%GCV) values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable Cmax samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.536" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="5.18" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="17.3" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="21.1" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="34.3" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="205" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="585" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="1580" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="3550" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="10900" spread="37.1"/>
                    <measurement group_id="O11" value="12300" spread="21.8"/>
                    <measurement group_id="O12" value="21800" spread="13.3"/>
                    <measurement group_id="O13" value="23300" spread="40.7"/>
                    <measurement group_id="O14" value="38100" spread="28.5"/>
                    <measurement group_id="O15" value="58600" spread="16.2"/>
                    <measurement group_id="O16" value="68600" spread="25.1"/>
                    <measurement group_id="O17" value="96500" spread="25.8"/>
                    <measurement group_id="O18" value="149000" spread="16.6"/>
                    <measurement group_id="O19" value="195000" spread="44.4"/>
                    <measurement group_id="O20" value="301000" spread="18.8"/>
                    <measurement group_id="O21" value="1790" spread="16.6"/>
                    <measurement group_id="O22" value="3670" spread="72.9"/>
                    <measurement group_id="O23" value="5010" spread="39.7"/>
                    <measurement group_id="O24" value="16300" spread="32.2"/>
                    <measurement group_id="O25" value="16900" spread="51.1"/>
                    <measurement group_id="O26" value="20400" spread="5.75"/>
                    <measurement group_id="O27" value="26300" spread="32.1"/>
                    <measurement group_id="O28" value="28300" spread="44.5"/>
                    <measurement group_id="O29" value="55200" spread="17.2"/>
                    <measurement group_id="O30" value="85900" spread="12.7"/>
                    <measurement group_id="O31" value="109000" spread="8.9"/>
                    <measurement group_id="O32" value="144000" spread="2.8"/>
                    <measurement group_id="O33" value="210000" spread="11.8"/>
                    <measurement group_id="O34" value="234000" spread="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0225" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="48.2" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="50.2" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="533" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="1490" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="607" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="11400" spread="42.0"/>
                    <measurement group_id="O11" value="13700" spread="46.6"/>
                    <measurement group_id="O12" value="14400" spread="92.7"/>
                    <measurement group_id="O13" value="31900" spread="27.2"/>
                    <measurement group_id="O14" value="77100" spread="140.5"/>
                    <measurement group_id="O15" value="51500" spread="38.3"/>
                    <measurement group_id="O16" value="115000" spread="59.1"/>
                    <measurement group_id="O17" value="120000" spread="59.2"/>
                    <measurement group_id="O18" value="168000" spread="20.0"/>
                    <measurement group_id="O19" value="228000" spread="45.7"/>
                    <measurement group_id="O20" value="364000" spread="33.5"/>
                    <measurement group_id="O21" value="660" spread="46.3"/>
                    <measurement group_id="O22" value="4010" spread="11.4"/>
                    <measurement group_id="O23" value="541" spread="31149.1"/>
                    <measurement group_id="O24" value="18500" spread="17.5"/>
                    <measurement group_id="O25" value="17900" spread="52.5"/>
                    <measurement group_id="O26" value="27900" spread="7.4"/>
                    <measurement group_id="O27" value="32500" spread="36.2"/>
                    <measurement group_id="O28" value="38100" spread="25.6"/>
                    <measurement group_id="O29" value="65000" spread="20.7"/>
                    <measurement group_id="O30" value="105000" spread="21.6"/>
                    <measurement group_id="O31" value="118000" spread="14.7"/>
                    <measurement group_id="O32" value="175000" spread="3.2"/>
                    <measurement group_id="O33" value="271000" spread="8.1"/>
                    <measurement group_id="O34" value="231000" spread="173.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.767" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="68.8" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="179" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="8940" spread="100.6"/>
                    <measurement group_id="O11" value="13400" spread="37.5"/>
                    <measurement group_id="O12" value="16200" spread="68.9"/>
                    <measurement group_id="O13" value="29100" spread="53.5"/>
                    <measurement group_id="O14" value="42000" spread="16.3"/>
                    <measurement group_id="O15" value="52700" spread="45.8"/>
                    <measurement group_id="O16" value="88700" spread="11.8"/>
                    <measurement group_id="O17" value="115000" spread="49.4"/>
                    <measurement group_id="O18" value="147000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="247000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="389000" spread="24.4"/>
                    <measurement group_id="O21" value="803" spread="26.2"/>
                    <measurement group_id="O22" value="3600" spread="361.8"/>
                    <measurement group_id="O23" value="2190" spread="263.1"/>
                    <measurement group_id="O24" value="18800" spread="41.8"/>
                    <measurement group_id="O25" value="17400" spread="72.1"/>
                    <measurement group_id="O26" value="30300" spread="11.0"/>
                    <measurement group_id="O27" value="37300" spread="23.4"/>
                    <measurement group_id="O28" value="48800" spread="45.6"/>
                    <measurement group_id="O29" value="96800" spread="62.8"/>
                    <measurement group_id="O30" value="111000" spread="20.6"/>
                    <measurement group_id="O31" value="117000" spread="35.7"/>
                    <measurement group_id="O32" value="193000" spread="18.1"/>
                    <measurement group_id="O33" value="321000" spread="19.3"/>
                    <measurement group_id="O34" value="333000" spread="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="2"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="7870" spread="126.1"/>
                    <measurement group_id="O12" value="13100" spread="115.8"/>
                    <measurement group_id="O13" value="20800" spread="44.2"/>
                    <measurement group_id="O14" value="38800" spread="39.1"/>
                    <measurement group_id="O15" value="67300" spread="47.9"/>
                    <measurement group_id="O16" value="88800" spread="18.3"/>
                    <measurement group_id="O17" value="86800" spread="28.8"/>
                    <measurement group_id="O19" value="256000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="501000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O21" value="42.9" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="10400" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="14200" spread="48.0"/>
                    <measurement group_id="O25" value="16900" spread="110.1"/>
                    <measurement group_id="O26" value="26600" spread="12.3"/>
                    <measurement group_id="O28" value="40600" spread="43.7"/>
                    <measurement group_id="O29" value="43200" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="126000" spread="42.5"/>
                    <measurement group_id="O31" value="207000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="318000" spread="2.0"/>
                    <measurement group_id="O34" value="386000" spread="22.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Maximum Concentration (Tmax) of MK-4166 Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Tmax. Tmax was defined as time to the maximum concentration of MK-4166 reached. MK-4166 Tmax was reported by dose cohort.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable Tmax samples. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Maximum Concentration (Tmax) of MK-4166 Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 Tmax. Tmax was defined as time to the maximum concentration of MK-4166 reached. MK-4166 Tmax was reported by dose cohort.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable Tmax samples. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" lower_limit="0.96" upper_limit="0.96"/>
                    <measurement group_id="O2" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O3" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O4" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O5" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O6" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O7" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O8" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O9" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O10" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O11" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O12" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O13" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O14" value="0.03" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O15" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O16" value="0.03" lower_limit="0.02" upper_limit="1.10"/>
                    <measurement group_id="O17" value="0.02" lower_limit="0.02" upper_limit="1.11"/>
                    <measurement group_id="O18" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O19" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O20" value="0.08" lower_limit="0.02" upper_limit="1.06"/>
                    <measurement group_id="O21" value="0.03" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O22" value="0.03" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O23" value="0.08" lower_limit="0.03" upper_limit="0.09"/>
                    <measurement group_id="O24" value="0.08" lower_limit="0.03" upper_limit="0.09"/>
                    <measurement group_id="O25" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O27" value="0.04" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O28" value="0.03" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O29" value="0.08" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O30" value="0.04" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O31" value="0.03" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O32" value="0.08" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O33" value="0.05" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O34" value="0.08" lower_limit="0.02" upper_limit="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.98" lower_limit="6.98" upper_limit="6.98"/>
                    <measurement group_id="O4" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O5" value="0.04" lower_limit="0.04" upper_limit="0.04"/>
                    <measurement group_id="O6" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O8" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O9" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O10" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O11" value="0.03" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O12" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O13" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O14" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O15" value="0.07" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O16" value="0.47" lower_limit="0.02" upper_limit="0.91"/>
                    <measurement group_id="O17" value="0.02" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O18" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O19" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O20" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O21" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O22" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O23" value="0.02" lower_limit="0.02" upper_limit="0.1"/>
                    <measurement group_id="O24" value="0.02" lower_limit="0.02" upper_limit="0.9"/>
                    <measurement group_id="O25" value="0.08" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O27" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O28" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O29" value="0.03" lower_limit="0.02" upper_limit="0.90"/>
                    <measurement group_id="O30" value="0.08" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O31" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O32" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O33" value="0.06" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O34" value="0.08" lower_limit="0.02" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O5" value="0.04" lower_limit="0.04" upper_limit="0.04"/>
                    <measurement group_id="O9" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O10" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O11" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O12" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O13" value="0.03" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O14" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O15" value="0.02" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O16" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O17" value="0.08" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O18" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O19" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O20" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O21" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O22" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O23" value="0.06" lower_limit="0.04" upper_limit="0.09"/>
                    <measurement group_id="O24" value="0.02" lower_limit="0.02" upper_limit="0.11"/>
                    <measurement group_id="O25" value="0.08" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O27" value="0.08" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O28" value="0.03" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O29" value="0.08" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O30" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O31" value="0.02" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O32" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O33" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O34" value="0.03" lower_limit="0.02" upper_limit="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="2"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="0.06" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O12" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O13" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O14" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O15" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O16" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O17" value="0.06" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O19" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O20" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O21" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O23" value="0.09" lower_limit="0.09" upper_limit="0.09"/>
                    <measurement group_id="O24" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O25" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O28" value="0.08" lower_limit="0.03" upper_limit="0.08"/>
                    <measurement group_id="O29" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O30" value="0.05" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O31" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O33" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O34" value="0.08" lower_limit="0.02" upper_limit="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Terminal Half-Life (t ½) of MK-4166 Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 t½. t½ was defined as the time required to divide the MK-4166 plasma concentration by two after reaching pseudo-equilibrium, following a single dose of MK-4166. MK-4166 t½ was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable t½ samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Terminal Half-Life (t ½) of MK-4166 Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 t½. t½ was defined as the time required to divide the MK-4166 plasma concentration by two after reaching pseudo-equilibrium, following a single dose of MK-4166. MK-4166 t½ was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable t½ samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.61" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="2.74" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="2.68" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="3.48" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="2.73" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="2.10" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="3.39" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="3.30" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="7.62" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="7.7" spread="67.2"/>
                    <measurement group_id="O11" value="7.49" spread="107.2"/>
                    <measurement group_id="O12" value="2.93" spread="85.2"/>
                    <measurement group_id="O13" value="12.8" spread="27.6"/>
                    <measurement group_id="O14" value="6.37" spread="87.7"/>
                    <measurement group_id="O15" value="7.66" spread="31.4"/>
                    <measurement group_id="O16" value="5.17" spread="126.5"/>
                    <measurement group_id="O17" value="12.0" spread="69.2"/>
                    <measurement group_id="O18" value="11.3" spread="22.7"/>
                    <measurement group_id="O19" value="13.1" spread="37.2"/>
                    <measurement group_id="O20" value="12.3" spread="4.5"/>
                    <measurement group_id="O21" value="2.86" spread="9.63"/>
                    <measurement group_id="O22" value="3.64" spread="27.7"/>
                    <measurement group_id="O23" value="6.15" spread="78.5"/>
                    <measurement group_id="O24" value="12.0" spread="60.9"/>
                    <measurement group_id="O25" value="7.31" spread="48.9"/>
                    <measurement group_id="O26" value="8.60" spread="66.6"/>
                    <measurement group_id="O27" value="8.84" spread="14.3"/>
                    <measurement group_id="O28" value="10.9" spread="28.8"/>
                    <measurement group_id="O29" value="11.9" spread="12.0"/>
                    <measurement group_id="O30" value="13.0" spread="10.6"/>
                    <measurement group_id="O31" value="7.81" spread="120.0"/>
                    <measurement group_id="O32" value="13.4" spread="37.4"/>
                    <measurement group_id="O33" value="9.03" spread="77.4"/>
                    <measurement group_id="O34" value="12.0" spread="70.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" spread="NA">NA = t½ was not calculable.</measurement>
                    <measurement group_id="O4" value="2.31" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="3.22" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="3.42" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="1.88" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = t½ was not calculable.</measurement>
                    <measurement group_id="O10" value="4.53" spread="171.6"/>
                    <measurement group_id="O11" value="7.21" spread="167.8"/>
                    <measurement group_id="O12" value="1.31" spread="2100.9"/>
                    <measurement group_id="O13" value="9.95" spread="38.4"/>
                    <measurement group_id="O14" value="5.82" spread="65.6"/>
                    <measurement group_id="O15" value="8.97" spread="39.5"/>
                    <measurement group_id="O16" value="11.4" spread="123.7"/>
                    <measurement group_id="O17" value="13.1" spread="32.8"/>
                    <measurement group_id="O18" value="10.2" spread="13.0"/>
                    <measurement group_id="O19" value="11.2" spread="49.6"/>
                    <measurement group_id="O20" value="14.1" spread="36.7"/>
                    <measurement group_id="O21" value="3.74" spread="486.6"/>
                    <measurement group_id="O22" value="1.38" spread="158.1"/>
                    <measurement group_id="O23" value="4.55" spread="318"/>
                    <measurement group_id="O24" value="10.5" spread="62.9"/>
                    <measurement group_id="O25" value="6.92" spread="82.0"/>
                    <measurement group_id="O26" value="5.82" spread="33.3"/>
                    <measurement group_id="O27" value="11.7" spread="14.3"/>
                    <measurement group_id="O28" value="9.22" spread="106.0"/>
                    <measurement group_id="O29" value="12.4" spread="36.6"/>
                    <measurement group_id="O30" value="15.7" spread="10.9"/>
                    <measurement group_id="O31" value="7.43" spread="111.8"/>
                    <measurement group_id="O32" value="11.7" spread="12.3"/>
                    <measurement group_id="O33" value="16.2" spread="5.36"/>
                    <measurement group_id="O34" value="13.2" spread="56.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="2"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.34" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="1.76" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = t½ was not calculable.</measurement>
                    <measurement group_id="O10" value="3.11" spread="120.5"/>
                    <measurement group_id="O11" value="4.52" spread="376.5"/>
                    <measurement group_id="O12" value="11.9" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="6.54" spread="54.0"/>
                    <measurement group_id="O14" value="9.59" spread="44.8"/>
                    <measurement group_id="O15" value="3.61" spread="787.8"/>
                    <measurement group_id="O16" value="11.9" spread="12.4"/>
                    <measurement group_id="O17" value="11.9" spread="29.2"/>
                    <measurement group_id="O18" value="11.3" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="10.4" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="21.4" spread="60"/>
                    <measurement group_id="O21" value="2.19" spread="394.0"/>
                    <measurement group_id="O22" value="3.72" spread="88.5"/>
                    <measurement group_id="O23" value="16.6" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="10.4" spread="95.0"/>
                    <measurement group_id="O25" value="7.32" spread="92.3"/>
                    <measurement group_id="O26" value="5.10" spread="23.4"/>
                    <measurement group_id="O27" value="7.91" spread="23.9"/>
                    <measurement group_id="O28" value="9.97" spread="30.5"/>
                    <measurement group_id="O29" value="12.3" spread="46.1"/>
                    <measurement group_id="O30" value="22.1" spread="50.8"/>
                    <measurement group_id="O31" value="5.75" spread="269.1"/>
                    <measurement group_id="O32" value="17.6" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="15.7" spread="18.6"/>
                    <measurement group_id="O34" value="21.6" spread="85.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="1"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="2.04" spread="706.9"/>
                    <measurement group_id="O12" value="8.79" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="2.59" spread="220.3"/>
                    <measurement group_id="O14" value="NA" spread="NA">NA = t½ was not calculable.</measurement>
                    <measurement group_id="O15" value="7.43" spread="139.3"/>
                    <measurement group_id="O16" value="8.14" spread="11.5"/>
                    <measurement group_id="O17" value="17.8" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="3.91" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O21" value="NA">NA = t½ was not calculable.</measurement>
                    <measurement group_id="O23" value="7.12" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="6.68" spread="103.1"/>
                    <measurement group_id="O25" value="13.1" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="6.27" spread="8.1"/>
                    <measurement group_id="O28" value="13.8" spread="34.5"/>
                    <measurement group_id="O29" value="14.8" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="16.4" spread="27.6"/>
                    <measurement group_id="O31" value="13.0" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="12.0" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="17.2" spread="48.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of MK-4166 from time zero to 21 hours after dosing. MK-4166 AUC0-21 was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Day 2. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-21 samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of MK-4166 from time zero to 21 hours after dosing. MK-4166 AUC0-21 was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-21 samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="3.91" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="24.7" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="39.0" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="69.4" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="672" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="3140" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="8300" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="19100" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="84700" spread="36.5"/>
                    <measurement group_id="O11" value="111000" spread="32.9"/>
                    <measurement group_id="O12" value="142000" spread="31.1"/>
                    <measurement group_id="O13" value="226000" spread="46.3"/>
                    <measurement group_id="O14" value="291000" spread="39.6"/>
                    <measurement group_id="O15" value="457000" spread="23.3"/>
                    <measurement group_id="O16" value="426000" spread="30.4"/>
                    <measurement group_id="O17" value="770000" spread="59.0"/>
                    <measurement group_id="O18" value="1110000" spread="21.4"/>
                    <measurement group_id="O19" value="1730000" spread="28.7"/>
                    <measurement group_id="O20" value="3110000" spread="17.5"/>
                    <measurement group_id="O21" value="7700" spread="32.6"/>
                    <measurement group_id="O22" value="19900" spread="87.1"/>
                    <measurement group_id="O23" value="33800" spread="89.1"/>
                    <measurement group_id="O24" value="137000" spread="41.4"/>
                    <measurement group_id="O25" value="119000" spread="71.4"/>
                    <measurement group_id="O26" value="147000" spread="25.9"/>
                    <measurement group_id="O27" value="271000" spread="25"/>
                    <measurement group_id="O28" value="248000" spread="57.6"/>
                    <measurement group_id="O29" value="516000" spread="21.1"/>
                    <measurement group_id="O30" value="832000" spread="11.4"/>
                    <measurement group_id="O31" value="986000" spread="26.2"/>
                    <measurement group_id="O32" value="137000" spread="7.7"/>
                    <measurement group_id="O33" value="1740000" spread="50.3"/>
                    <measurement group_id="O34" value="2130000" spread="27.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.141" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="126" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="118" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="2610" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="3510" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="48600" spread="226.2"/>
                    <measurement group_id="O11" value="51800" spread="660.7"/>
                    <measurement group_id="O12" value="14500" spread="19927.0"/>
                    <measurement group_id="O13" value="273000" spread="50.1"/>
                    <measurement group_id="O14" value="223000" spread="45.6"/>
                    <measurement group_id="O15" value="401000" spread="55.9"/>
                    <measurement group_id="O16" value="860000" spread="53.4"/>
                    <measurement group_id="O17" value="1160000" spread="72.1"/>
                    <measurement group_id="O18" value="1590000" spread="33.3"/>
                    <measurement group_id="O19" value="2090000" spread="19.8"/>
                    <measurement group_id="O20" value="4580000" spread="21.1"/>
                    <measurement group_id="O21" value="1120" spread="120.6"/>
                    <measurement group_id="O22" value="7330" spread="150.8"/>
                    <measurement group_id="O23" value="6380" spread="503154.6"/>
                    <measurement group_id="O24" value="167000" spread="56.9"/>
                    <measurement group_id="O25" value="116000" spread="121.4"/>
                    <measurement group_id="O26" value="216000" spread="32.4"/>
                    <measurement group_id="O27" value="278000" spread="37.1"/>
                    <measurement group_id="O28" value="279000" spread="84.3"/>
                    <measurement group_id="O29" value="594000" spread="27.1"/>
                    <measurement group_id="O30" value="1170000" spread="15.1"/>
                    <measurement group_id="O31" value="678000" spread="305.7"/>
                    <measurement group_id="O32" value="1760000" spread="11.9"/>
                    <measurement group_id="O33" value="3280000" spread="5.08"/>
                    <measurement group_id="O34" value="2880000" spread="49.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="2"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.893" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="135" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = AUC0-21 was not calculable.</measurement>
                    <measurement group_id="O10" value="17400" spread="711.2"/>
                    <measurement group_id="O11" value="55700" spread="733.9"/>
                    <measurement group_id="O12" value="235000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="217000" spread="87.0"/>
                    <measurement group_id="O14" value="306000" spread="32.2"/>
                    <measurement group_id="O15" value="173000" spread="658.5"/>
                    <measurement group_id="O16" value="749000" spread="6.8"/>
                    <measurement group_id="O17" value="1180000" spread="69.4"/>
                    <measurement group_id="O18" value="1370000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="2390000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="5410000" spread="4.01"/>
                    <measurement group_id="O21" value="1110" spread="104.1"/>
                    <measurement group_id="O22" value="33900" spread="8.86"/>
                    <measurement group_id="O23" value="79300" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="182000" spread="81.4"/>
                    <measurement group_id="O25" value="123000" spread="156.1"/>
                    <measurement group_id="O26" value="152000" spread="11.5"/>
                    <measurement group_id="O27" value="301000" spread="27.7"/>
                    <measurement group_id="O28" value="330000" spread="79.3"/>
                    <measurement group_id="O29" value="631000" spread="10.4"/>
                    <measurement group_id="O30" value="1310000" spread="18.8"/>
                    <measurement group_id="O31" value="692000" spread="277.7"/>
                    <measurement group_id="O32" value="2220000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="3440000" spread="7.9"/>
                    <measurement group_id="O34" value="3790000" spread="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="1"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="18500" spread="8160.0"/>
                    <measurement group_id="O12" value="250000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="80600" spread="247.9"/>
                    <measurement group_id="O14" value="NA" spread="NA">NA = AUC0-21 was not calculable.</measurement>
                    <measurement group_id="O15" value="503000" spread="133.9"/>
                    <measurement group_id="O16" value="716000" spread="0.359"/>
                    <measurement group_id="O17" value="1410000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="1400000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="NA">NA = AUC0-21 was not calculable.</measurement>
                    <measurement group_id="O21" value="NA">NA = AUC0-21 was not calculable.</measurement>
                    <measurement group_id="O23" value="80400" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="107000" spread="136.8"/>
                    <measurement group_id="O25" value="353000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="148000" spread="24.9"/>
                    <measurement group_id="O28" value="394000" spread="66.0"/>
                    <measurement group_id="O29" value="575000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="1580000" spread="46.2"/>
                    <measurement group_id="O31" value="2350000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="3800000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="4360000" spread="33.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-last. AUC0-last was defined as the area under the concentration-time curve of MK-4166 from time zero to the last quantifiable sample. MK-4166 AUC0-last was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-last samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-last. AUC0-last was defined as the area under the concentration-time curve of MK-4166 from time zero to the last quantifiable sample. MK-4166 AUC0-last was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-last samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="3.89" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="24.6" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="39.0" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="69.4" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="672" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="3010" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="8300" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="14300" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="79500" spread="34.6"/>
                    <measurement group_id="O11" value="111000" spread="32.7"/>
                    <measurement group_id="O12" value="141000" spread="31.6"/>
                    <measurement group_id="O13" value="226000" spread="46.4"/>
                    <measurement group_id="O14" value="290000" spread="39.4"/>
                    <measurement group_id="O15" value="451000" spread="23.9"/>
                    <measurement group_id="O16" value="354000" spread="51.6"/>
                    <measurement group_id="O17" value="677000" spread="82.2"/>
                    <measurement group_id="O18" value="1170000" spread="31.1"/>
                    <measurement group_id="O19" value="1720000" spread="29.0"/>
                    <measurement group_id="O20" value="3310000" spread="17.1"/>
                    <measurement group_id="O21" value="7700" spread="32.6"/>
                    <measurement group_id="O22" value="14100" spread="57.6"/>
                    <measurement group_id="O23" value="31900" spread="88.8"/>
                    <measurement group_id="O24" value="137000" spread="41.5"/>
                    <measurement group_id="O25" value="120000" spread="71.0"/>
                    <measurement group_id="O26" value="142000" spread="31.9"/>
                    <measurement group_id="O27" value="200000" spread="76.6"/>
                    <measurement group_id="O28" value="248000" spread="57.5"/>
                    <measurement group_id="O29" value="477000" spread="16.2"/>
                    <measurement group_id="O30" value="830000" spread="11.3"/>
                    <measurement group_id="O31" value="967000" spread="25.3"/>
                    <measurement group_id="O32" value="738000" spread="141.5"/>
                    <measurement group_id="O33" value="1280000" spread="126.2"/>
                    <measurement group_id="O34" value="2140000" spread="27.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0632" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="86.9" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="118" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="2010" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="1780" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="21.1" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="48600" spread="226.2"/>
                    <measurement group_id="O11" value="51600" spread="660.6"/>
                    <measurement group_id="O12" value="14400" spread="20883.7"/>
                    <measurement group_id="O13" value="268000" spread="49.1"/>
                    <measurement group_id="O14" value="223000" spread="45.3"/>
                    <measurement group_id="O15" value="128000" spread="759.0"/>
                    <measurement group_id="O16" value="864000" spread="54.7"/>
                    <measurement group_id="O17" value="1160000" spread="72.3"/>
                    <measurement group_id="O18" value="635000" spread="247.7"/>
                    <measurement group_id="O19" value="1790000" spread="31.7"/>
                    <measurement group_id="O20" value="2620000" spread="116.6"/>
                    <measurement group_id="O21" value="1110" spread="118.9"/>
                    <measurement group_id="O22" value="6510" spread="182.3"/>
                    <measurement group_id="O23" value="309" spread="4954684876.5"/>
                    <measurement group_id="O24" value="167000" spread="56.9"/>
                    <measurement group_id="O25" value="115000" spread="121.4"/>
                    <measurement group_id="O26" value="228000" spread="40.9"/>
                    <measurement group_id="O27" value="280000" spread="35.7"/>
                    <measurement group_id="O28" value="280000" spread="83.6"/>
                    <measurement group_id="O29" value="616000" spread="25.9"/>
                    <measurement group_id="O30" value="1170000" spread="13.7"/>
                    <measurement group_id="O31" value="681000" spread="307.0"/>
                    <measurement group_id="O32" value="1710000" spread="15.7"/>
                    <measurement group_id="O33" value="3770000" spread="25.4"/>
                    <measurement group_id="O34" value="1710000" spread="371.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.879" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="135" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="7.48" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="19600" spread="351.9"/>
                    <measurement group_id="O11" value="51400" spread="640.7"/>
                    <measurement group_id="O12" value="25300" spread="14504.2"/>
                    <measurement group_id="O13" value="172000" spread="69.1"/>
                    <measurement group_id="O14" value="281000" spread="19.5"/>
                    <measurement group_id="O15" value="168000" spread="728.3"/>
                    <measurement group_id="O16" value="756000" spread="5.0"/>
                    <measurement group_id="O17" value="1110000" spread="59.1"/>
                    <measurement group_id="O18" value="1110000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="2400000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="1910000" spread="294"/>
                    <measurement group_id="O21" value="740" spread="53.9"/>
                    <measurement group_id="O22" value="4070" spread="18558.6"/>
                    <measurement group_id="O23" value="5130" spread="177486.3"/>
                    <measurement group_id="O24" value="162000" spread="63.3"/>
                    <measurement group_id="O25" value="118000" spread="153.4"/>
                    <measurement group_id="O26" value="153000" spread="12.2"/>
                    <measurement group_id="O27" value="219000" spread="18.5"/>
                    <measurement group_id="O28" value="323000" spread="80.9"/>
                    <measurement group_id="O29" value="579000" spread="14.8"/>
                    <measurement group_id="O30" value="638000" spread="195.6"/>
                    <measurement group_id="O31" value="443000" spread="353.2"/>
                    <measurement group_id="O32" value="473000" spread="480.0"/>
                    <measurement group_id="O33" value="3480000" spread="6.2"/>
                    <measurement group_id="O34" value="3920000" spread="29.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="2"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="11500" spread="4140.6"/>
                    <measurement group_id="O12" value="14600" spread="18895.8"/>
                    <measurement group_id="O13" value="61500" spread="136.5"/>
                    <measurement group_id="O14" value="79100" spread="265.0"/>
                    <measurement group_id="O15" value="184000" spread="174.6"/>
                    <measurement group_id="O16" value="379000" spread="5.5"/>
                    <measurement group_id="O17" value="254000" spread="175.0"/>
                    <measurement group_id="O19" value="433000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="469000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O21" value="1.72" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="46000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="80800" spread="140.8"/>
                    <measurement group_id="O25" value="12600" spread="1377431.1"/>
                    <measurement group_id="O26" value="142000" spread="39.4"/>
                    <measurement group_id="O28" value="365000" spread="44.1"/>
                    <measurement group_id="O29" value="574000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="1580000" spread="46.6"/>
                    <measurement group_id="O31" value="2280000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="975000" spread="99.2"/>
                    <measurement group_id="O34" value="2750000" spread="135.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to Infinity (AUC 0-inf) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of MK-4166 from time zero to infinity. MK-4166 AUC0-inf was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-inf samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of MK-4166 From Time Zero to Infinity (AUC 0-inf) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of MK-4166 from time zero to infinity. MK-4166 AUC0-inf was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable AUC0-inf samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="3.92" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="24.8" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="39.3" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="69.5" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="673" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="3190" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="8420" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="29400" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="105000" spread="54"/>
                    <measurement group_id="O11" value="141000" spread="55.5"/>
                    <measurement group_id="O12" value="148000" spread="37.7"/>
                    <measurement group_id="O13" value="333000" spread="59.5"/>
                    <measurement group_id="O14" value="345000" spread="54.4"/>
                    <measurement group_id="O15" value="558000" spread="31.1"/>
                    <measurement group_id="O16" value="501000" spread="51.5"/>
                    <measurement group_id="O17" value="1120000" spread="67.1"/>
                    <measurement group_id="O18" value="1500000" spread="17.2"/>
                    <measurement group_id="O19" value="2580000" spread="9.88"/>
                    <measurement group_id="O20" value="4520000" spread="19.2"/>
                    <measurement group_id="O21" value="7750" spread="32.8"/>
                    <measurement group_id="O22" value="20600" spread="89.4"/>
                    <measurement group_id="O23" value="40200" spread="121.9"/>
                    <measurement group_id="O24" value="200000" spread="74.6"/>
                    <measurement group_id="O25" value="142000" spread="90.1"/>
                    <measurement group_id="O26" value="187000" spread="46.0"/>
                    <measurement group_id="O27" value="336000" spread="23.4"/>
                    <measurement group_id="O28" value="338000" spread="76.2"/>
                    <measurement group_id="O29" value="730000" spread="15.9"/>
                    <measurement group_id="O30" value="1240000" spread="12.4"/>
                    <measurement group_id="O31" value="1300000" spread="52.3"/>
                    <measurement group_id="O32" value="2090000" spread="26.2"/>
                    <measurement group_id="O33" value="2340000" spread="77.0"/>
                    <measurement group_id="O34" value="3200000" spread="43.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O4" value="126" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="118" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="2660" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="3490" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O10" value="58600" spread="326.9"/>
                    <measurement group_id="O11" value="68800" spread="1111.6"/>
                    <measurement group_id="O12" value="15400" spread="28630.7"/>
                    <measurement group_id="O13" value="360000" spread="68.6"/>
                    <measurement group_id="O14" value="252000" spread="59.2"/>
                    <measurement group_id="O15" value="503000" spread="78.7"/>
                    <measurement group_id="O16" value="1280000" spread="6.1"/>
                    <measurement group_id="O17" value="1740000" spread="71.9"/>
                    <measurement group_id="O18" value="2090000" spread="39.2"/>
                    <measurement group_id="O19" value="2950000" spread="4.1"/>
                    <measurement group_id="O20" value="7270000" spread="0.2"/>
                    <measurement group_id="O21" value="1550" spread="49.7"/>
                    <measurement group_id="O22" value="7010" spread="176.2"/>
                    <measurement group_id="O23" value="7660" spread="2164569.0"/>
                    <measurement group_id="O24" value="232000" spread="92.0"/>
                    <measurement group_id="O25" value="141000" spread="168.9"/>
                    <measurement group_id="O26" value="238000" spread="40.4"/>
                    <measurement group_id="O27" value="392000" spread="38.9"/>
                    <measurement group_id="O28" value="385000" spread="150.0"/>
                    <measurement group_id="O29" value="849000" spread="15.3"/>
                    <measurement group_id="O30" value="1930000" spread="20.7"/>
                    <measurement group_id="O31" value="874000" spread="450.1"/>
                    <measurement group_id="O32" value="2500000" spread="18.6"/>
                    <measurement group_id="O33" value="5570000" spread="8.3"/>
                    <measurement group_id="O34" value="4520000" spread="70.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="2"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.896" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="135" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O10" value="18700" spread="896.0"/>
                    <measurement group_id="O11" value="70000" spread="1119.8"/>
                    <measurement group_id="O12" value="330000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="251000" spread="105.1"/>
                    <measurement group_id="O14" value="396000" spread="53.5"/>
                    <measurement group_id="O15" value="216000" spread="1232.6"/>
                    <measurement group_id="O16" value="1050000" spread="2.7"/>
                    <measurement group_id="O17" value="1690000" spread="69.9"/>
                    <measurement group_id="O18" value="1880000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="3190000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="11300000" spread="33.8"/>
                    <measurement group_id="O21" value="1210" spread="104.1"/>
                    <measurement group_id="O22" value="35700" spread="1.4"/>
                    <measurement group_id="O23" value="136000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="261000" spread="123.7"/>
                    <measurement group_id="O25" value="155000" spread="236.1"/>
                    <measurement group_id="O26" value="162000" spread="15.6"/>
                    <measurement group_id="O27" value="360000" spread="28.9"/>
                    <measurement group_id="O28" value="430000" spread="86.6"/>
                    <measurement group_id="O29" value="915000" spread="17.1"/>
                    <measurement group_id="O30" value="2740000" spread="52.3"/>
                    <measurement group_id="O31" value="909000" spread="438.2"/>
                    <measurement group_id="O32" value="3910000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="5690000" spread="2.23"/>
                    <measurement group_id="O34" value="8000000" spread="82.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="1"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="18200" spread="20134.8"/>
                    <measurement group_id="O12" value="309000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="85500" spread="284.2"/>
                    <measurement group_id="O14" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O15" value="644000" spread="228.9"/>
                    <measurement group_id="O16" value="862000" spread="4.6"/>
                    <measurement group_id="O17" value="2520000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="1460000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O21" value="NA" spread="NA">NA = AUC0-inf was not calculable.</measurement>
                    <measurement group_id="O23" value="92300" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="129000" spread="200.9"/>
                    <measurement group_id="O25" value="524000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="164000" spread="22.9"/>
                    <measurement group_id="O28" value="609000" spread="96.4"/>
                    <measurement group_id="O29" value="914000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="2720000" spread="67.4"/>
                    <measurement group_id="O31" value="3480000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="5400000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="7910000" spread="54.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apparent Clearance (CL) of MK-4166 Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 CL. CL was defined as the volume of plasma from which MK-4166 is eliminated per unit time following IV MK-4166 administration. MK-4166 CL was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable CL samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Clearance (CL) of MK-4166 Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 CL. CL was defined as the volume of plasma from which MK-4166 is eliminated per unit time following IV MK-4166 administration. MK-4166 CL was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable CL samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Liters (L)/day</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="1.15" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="0.565" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="1.02" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="1.73" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="0.550" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="0.344" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="0.392" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="0.341" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="0.286" spread="54.0"/>
                    <measurement group_id="O11" value="0.299" spread="55.5"/>
                    <measurement group_id="O12" value="0.400" spread="37.7"/>
                    <measurement group_id="O13" value="0.246" spread="59.5"/>
                    <measurement group_id="O14" value="0.348" spread="54.4"/>
                    <measurement group_id="O15" value="0.305" spread="31.1"/>
                    <measurement group_id="O16" value="0.479" spread="51.5"/>
                    <measurement group_id="O17" value="0.304" spread="67.1"/>
                    <measurement group_id="O18" value="0.320" spread="17.2"/>
                    <measurement group_id="O19" value="0.259" spread="9.9"/>
                    <measurement group_id="O20" value="0.199" spread="19.2"/>
                    <measurement group_id="O21" value="0.142" spread="32.8"/>
                    <measurement group_id="O22" value="0.161" spread="89.4"/>
                    <measurement group_id="O23" value="0.249" spread="122"/>
                    <measurement group_id="O24" value="0.150" spread="74.4"/>
                    <measurement group_id="O25" value="0.296" spread="90.1"/>
                    <measurement group_id="O26" value="0.315" spread="46.0"/>
                    <measurement group_id="O27" value="0.244" spread="23.4"/>
                    <measurement group_id="O28" value="0.302" spread="51.3"/>
                    <measurement group_id="O29" value="0.233" spread="15.9"/>
                    <measurement group_id="O30" value="0.193" spread="12.4"/>
                    <measurement group_id="O31" value="0.262" spread="52.3"/>
                    <measurement group_id="O32" value="0.230" spread="26.2"/>
                    <measurement group_id="O33" value="0.287" spread="77.0"/>
                    <measurement group_id="O34" value="0.279" spread="40.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="0.319" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="1.02" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="0.142" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="0.940" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = CL was not calculable.</measurement>
                    <measurement group_id="O10" value="0.617" spread="226.2"/>
                    <measurement group_id="O11" value="0.811" spread="660.7"/>
                    <measurement group_id="O12" value="4.06" spread="19927.0"/>
                    <measurement group_id="O13" value="0.301" spread="50.1"/>
                    <measurement group_id="O14" value="0.538" spread="45.6"/>
                    <measurement group_id="O15" value="0.424" spread="55.9"/>
                    <measurement group_id="O16" value="0.279" spread="53.4"/>
                    <measurement group_id="O17" value="0.293" spread="72.1"/>
                    <measurement group_id="O18" value="0.302" spread="33.3"/>
                    <measurement group_id="O19" value="0.321" spread="19.8"/>
                    <measurement group_id="O20" value="0.197" spread="21.1"/>
                    <measurement group_id="O21" value="0.98" spread="120.6"/>
                    <measurement group_id="O22" value="0.450" spread="150.8"/>
                    <measurement group_id="O23" value="1.57" spread="503154.6"/>
                    <measurement group_id="O24" value="0.182" spread="60.1"/>
                    <measurement group_id="O25" value="0.362" spread="121.4"/>
                    <measurement group_id="O26" value="0.273" spread="32.4"/>
                    <measurement group_id="O27" value="0.294" spread="37.1"/>
                    <measurement group_id="O28" value="0.430" spread="84.3"/>
                    <measurement group_id="O29" value="0.286" spread="27.1"/>
                    <measurement group_id="O30" value="0.205" spread="15.1"/>
                    <measurement group_id="O31" value="0.502" spread="305.7"/>
                    <measurement group_id="O32" value="0.272" spread="11.9"/>
                    <measurement group_id="O33" value="0.204" spread="5.1"/>
                    <measurement group_id="O34" value="0.313" spread="49.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="2"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.68" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="0.887" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = CL was not calculable.</measurement>
                    <measurement group_id="O10" value="1.73" spread="711.2"/>
                    <measurement group_id="O11" value="0.754" spread="733.9"/>
                    <measurement group_id="O12" value="0.251" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="0.378" spread="87.0"/>
                    <measurement group_id="O14" value="0.392" spread="32.2"/>
                    <measurement group_id="O15" value="0.982" spread="658.5"/>
                    <measurement group_id="O16" value="0.321" spread="6.8"/>
                    <measurement group_id="O17" value="0.288" spread="69.4"/>
                    <measurement group_id="O18" value="0.349" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="0.280" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="0.166" spread="4.0"/>
                    <measurement group_id="O21" value="0.987" spread="104.1"/>
                    <measurement group_id="O22" value="0.0973" spread="8.86"/>
                    <measurement group_id="O23" value="0.126" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="0.165" spread="81.4"/>
                    <measurement group_id="O25" value="0.341" spread="156.1"/>
                    <measurement group_id="O26" value="0.388" spread="11.5"/>
                    <measurement group_id="O27" value="0.273" spread="27.7"/>
                    <measurement group_id="O28" value="0.364" spread="79.3"/>
                    <measurement group_id="O29" value="0.269" spread="10.4"/>
                    <measurement group_id="O30" value="0.183" spread="18.8"/>
                    <measurement group_id="O31" value="0.491" spread="277.7"/>
                    <measurement group_id="O32" value="0.217" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="0.195" spread="7.9"/>
                    <measurement group_id="O34" value="0.238" spread="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="1"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="2.27" spread="8160.0"/>
                    <measurement group_id="O12" value="0.236" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="1.02" spread="247.9"/>
                    <measurement group_id="O14" value="NA" spread="NA">NA = CL was not calculable.</measurement>
                    <measurement group_id="O15" value="0.338" spread="133.9"/>
                    <measurement group_id="O16" value="0.335" spread="0.4"/>
                    <measurement group_id="O17" value="0.241" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="0.477" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="NA" spread="NA">NA = CL was not calculable.</measurement>
                    <measurement group_id="O21" value="NA" spread="NA">NA = CL was not calculable.</measurement>
                    <measurement group_id="O23" value="0.124" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="0.282" spread="136.8"/>
                    <measurement group_id="O25" value="0.119" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="0.398" spread="24.9"/>
                    <measurement group_id="O28" value="0.305" spread="66.0"/>
                    <measurement group_id="O29" value="0.296" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="0.152" spread="46.2"/>
                    <measurement group_id="O31" value="0.145" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="0.176" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="0.206" spread="33.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apparent Volume of Distribution (V) of MK-4166 Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered MK-4166 at the same concentration that it is observed in the blood plasma. MK-4166 V was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of MK-4166 infusion (up to 10 minutes), 2 hours; Days 2, 3, 5 (Cohorts 1-9 only), 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable V samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Volume of Distribution (V) of MK-4166 Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 and plasma isolated for analysis of MK-4166 V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered MK-4166 at the same concentration that it is observed in the blood plasma. MK-4166 V was reported by dose cohort. Per protocol, % GCV values were not reported for cohorts with n&lt;2 participants.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable V samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Liters</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="4"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="4"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.19" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O2" value="4.55" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="2.18" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="5.11" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="6.80" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="1.67" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="1.68" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="1.87" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="3.74" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="3.20" spread="32.6"/>
                    <measurement group_id="O11" value="3.23" spread="48.9"/>
                    <measurement group_id="O12" value="1.69" spread="49.7"/>
                    <measurement group_id="O13" value="4.56" spread="35.4"/>
                    <measurement group_id="O14" value="3.19" spread="69.7"/>
                    <measurement group_id="O15" value="3.37" spread="19.3"/>
                    <measurement group_id="O16" value="3.57" spread="79.9"/>
                    <measurement group_id="O17" value="5.27" spread="67.9"/>
                    <measurement group_id="O18" value="5.21" spread="34.4"/>
                    <measurement group_id="O19" value="4.92" spread="48.4"/>
                    <measurement group_id="O20" value="3.54" spread="17.1"/>
                    <measurement group_id="O21" value="0.587" spread="30.2"/>
                    <measurement group_id="O22" value="0.844" spread="55.6"/>
                    <measurement group_id="O23" value="2.21" spread="33.9"/>
                    <measurement group_id="O24" value="2.61" spread="10.8"/>
                    <measurement group_id="O25" value="3.12" spread="46.6"/>
                    <measurement group_id="O26" value="3.91" spread="22.6"/>
                    <measurement group_id="O27" value="3.11" spread="28.8"/>
                    <measurement group_id="O28" value="4.73" spread="21.2"/>
                    <measurement group_id="O29" value="4.01" spread="27.1"/>
                    <measurement group_id="O30" value="3.62" spread="14.0"/>
                    <measurement group_id="O31" value="2.95" spread="48.8"/>
                    <measurement group_id="O32" value="4.44" spread="10.4"/>
                    <measurement group_id="O33" value="3.74" spread="1.0"/>
                    <measurement group_id="O34" value="4.85" spread="38.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="3"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O4" value="1.10" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="2.49" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="0.722" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O8" value="2.41" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O10" value="3.75" spread="27.1"/>
                    <measurement group_id="O11" value="6.59" spread="46.1"/>
                    <measurement group_id="O12" value="3.91" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="4.25" spread="11.0"/>
                    <measurement group_id="O14" value="4.40" spread="14.9"/>
                    <measurement group_id="O15" value="5.10" spread="2.5"/>
                    <measurement group_id="O16" value="4.41" spread="263.0"/>
                    <measurement group_id="O17" value="5.44" spread="88.1"/>
                    <measurement group_id="O18" value="4.42" spread="21.1"/>
                    <measurement group_id="O19" value="5.19" spread="75.3"/>
                    <measurement group_id="O20" value="4.11" spread="63.3"/>
                    <measurement group_id="O21" value="5.61" spread="3589.3"/>
                    <measurement group_id="O22" value="0.870" spread="13.1"/>
                    <measurement group_id="O23" value="2.97" spread="96.8"/>
                    <measurement group_id="O24" value="2.76" spread="3.1"/>
                    <measurement group_id="O25" value="3.67" spread="35.8"/>
                    <measurement group_id="O26" value="2.41" spread="3.0"/>
                    <measurement group_id="O27" value="4.9" spread="40.3"/>
                    <measurement group_id="O28" value="5.89" spread="18.4"/>
                    <measurement group_id="O29" value="4.77" spread="58.9"/>
                    <measurement group_id="O30" value="4.58" spread="10.6"/>
                    <measurement group_id="O31" value="4.36" spread="23.7"/>
                    <measurement group_id="O32" value="4.68" spread="2.0"/>
                    <measurement group_id="O33" value="4.83" spread="0.5"/>
                    <measurement group_id="O34" value="5.94" spread="36.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="1"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="2"/>
                    <count group_id="O21" value="2"/>
                    <count group_id="O22" value="2"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="1.99" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O10" value="6.13" spread="84.5"/>
                    <measurement group_id="O11" value="4.76" spread="34.1"/>
                    <measurement group_id="O12" value="4.15" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="3.62" spread="28.9"/>
                    <measurement group_id="O14" value="5.14" spread="17.2"/>
                    <measurement group_id="O15" value="5.54" spread="8.6"/>
                    <measurement group_id="O16" value="5.25" spread="11.9"/>
                    <measurement group_id="O17" value="4.87" spread="83.3"/>
                    <measurement group_id="O18" value="5.53" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="4.24" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="5.2" spread="61.6"/>
                    <measurement group_id="O21" value="5.45" spread="862.6"/>
                    <measurement group_id="O22" value="0.499" spread="111.2"/>
                    <measurement group_id="O23" value="3.01" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="2.5" spread="42.7"/>
                    <measurement group_id="O25" value="3.56" spread="62.3"/>
                    <measurement group_id="O26" value="2.90" spread="8.8"/>
                    <measurement group_id="O27" value="3.10" spread="39.1"/>
                    <measurement group_id="O28" value="4.96" spread="69.5"/>
                    <measurement group_id="O29" value="4.62" spread="50.2"/>
                    <measurement group_id="O30" value="5.7" spread="25.2"/>
                    <measurement group_id="O31" value="3.97" spread="12.2"/>
                    <measurement group_id="O32" value="5.41" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="4.38" spread="25.2"/>
                    <measurement group_id="O34" value="7.23" spread="61.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="2"/>
                    <count group_id="O17" value="1"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="1"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O11" value="3.32" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O12" value="3.00" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="4.03" spread="16.5"/>
                    <measurement group_id="O14" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O15" value="3.55" spread="5.0"/>
                    <measurement group_id="O16" value="3.97" spread="12.0"/>
                    <measurement group_id="O17" value="6.16" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O19" value="2.82" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O21" value="NA" spread="NA">NA = V was not calculable.</measurement>
                    <measurement group_id="O23" value="1.27" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="2.71" spread="16.6"/>
                    <measurement group_id="O25" value="2.22" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="3.49" spread="32.9"/>
                    <measurement group_id="O28" value="5.93" spread="23.7"/>
                    <measurement group_id="O29" value="6.29" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="3.61" spread="16.4"/>
                    <measurement group_id="O31" value="2.72" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="3.04" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="5.14" spread="37.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Concentration (Cmax) of Pembrolizumab Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Cmax. Cmax was defined as the maximum concentration of pembrolizumab reached. Pembrolizumab Cmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable Cmax samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Concentration (Cmax) of Pembrolizumab Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Cmax. Cmax was defined as the maximum concentration of pembrolizumab reached. Pembrolizumab Cmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable Cmax samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="82400" spread="27.9"/>
                    <measurement group_id="O22" value="68500" spread="32.4"/>
                    <measurement group_id="O23" value="51700" spread="25.7"/>
                    <measurement group_id="O24" value="81700" spread="17.2"/>
                    <measurement group_id="O25" value="57600" spread="35.7"/>
                    <measurement group_id="O26" value="78400" spread="18.4"/>
                    <measurement group_id="O27" value="72600" spread="24.3"/>
                    <measurement group_id="O28" value="57700" spread="27.2"/>
                    <measurement group_id="O29" value="63300" spread="30.7"/>
                    <measurement group_id="O30" value="83700" spread="24.8"/>
                    <measurement group_id="O31" value="66900" spread="4.1"/>
                    <measurement group_id="O32" value="81600" spread="22.5"/>
                    <measurement group_id="O33" value="70400" spread="15.1"/>
                    <measurement group_id="O34" value="69900" spread="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="90000" spread="32.2"/>
                    <measurement group_id="O22" value="76800" spread="31.8"/>
                    <measurement group_id="O23" value="61300" spread="17.2"/>
                    <measurement group_id="O24" value="16200" spread="109.6"/>
                    <measurement group_id="O25" value="73000" spread="35.9"/>
                    <measurement group_id="O26" value="96800" spread="14.2"/>
                    <measurement group_id="O27" value="85700" spread="40.7"/>
                    <measurement group_id="O28" value="48700" spread="79.3"/>
                    <measurement group_id="O29" value="78500" spread="12.5"/>
                    <measurement group_id="O30" value="82300" spread="25.5"/>
                    <measurement group_id="O31" value="86000" spread="17.4"/>
                    <measurement group_id="O32" value="96600" spread="4.9"/>
                    <measurement group_id="O33" value="94100" spread="12.9"/>
                    <measurement group_id="O34" value="80100" spread="25.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="97200" spread="56.3"/>
                    <measurement group_id="O22" value="78400" spread="31.7"/>
                    <measurement group_id="O23" value="61600" spread="22.9"/>
                    <measurement group_id="O24" value="97200" spread="18.7"/>
                    <measurement group_id="O25" value="73000" spread="56.8"/>
                    <measurement group_id="O26" value="115000" spread="9.2"/>
                    <measurement group_id="O27" value="93100" spread="33.8"/>
                    <measurement group_id="O28" value="79100" spread="38.7"/>
                    <measurement group_id="O29" value="83200" spread="22.8"/>
                    <measurement group_id="O30" value="76000" spread="52.2"/>
                    <measurement group_id="O31" value="93200" spread="13.7"/>
                    <measurement group_id="O32" value="115000" spread="11.7"/>
                    <measurement group_id="O33" value="94100" spread="7.1"/>
                    <measurement group_id="O34" value="94600" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="156000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="54700" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="57000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="105000" spread="17.2"/>
                    <measurement group_id="O25" value="96500" spread="31.6"/>
                    <measurement group_id="O26" value="125000" spread="7.9"/>
                    <measurement group_id="O28" value="83500" spread="57.6"/>
                    <measurement group_id="O30" value="90800" spread="47.7"/>
                    <measurement group_id="O31" value="143000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="95600" spread="4.66"/>
                    <measurement group_id="O34" value="97400" spread="23.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Maximum Concentration (Tmax) of Pembrolizumab Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Tmax. Tmax was defined as time to the maximum concentration of pembrolizumab reached. Pembrolizumab Tmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable Tmax samples. Per protocol, MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Maximum Concentration (Tmax) of Pembrolizumab Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab Tmax. Tmax was defined as time to the maximum concentration of pembrolizumab reached. Pembrolizumab Tmax was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable Tmax samples. Per protocol, MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.03" lower_limit="0.03" upper_limit="0.15"/>
                    <measurement group_id="O22" value="0.06" lower_limit="0.03" upper_limit="0.13"/>
                    <measurement group_id="O23" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O24" value="0.08" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O25" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O26" value="0.03" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O27" value="0.06" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O28" value="0.04" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O29" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O30" value="0.11" lower_limit="0.08" upper_limit="0.14"/>
                    <measurement group_id="O31" value="0.07" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O32" value="0.02" lower_limit="0.02" upper_limit="0.06"/>
                    <measurement group_id="O33" value="0.05" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O34" value="0.02" lower_limit="0.02" upper_limit="13.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.03" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O22" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O23" value="0.03" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O24" value="0.03" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O25" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.05" lower_limit="0.03" upper_limit="0.07"/>
                    <measurement group_id="O27" value="0.03" lower_limit="0.03" upper_limit="0.07"/>
                    <measurement group_id="O28" value="0.13" lower_limit="0.03" upper_limit="14.1"/>
                    <measurement group_id="O29" value="0.05" lower_limit="0.03" upper_limit="0.07"/>
                    <measurement group_id="O30" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O31" value="0.06" lower_limit="0.06" upper_limit="0.13"/>
                    <measurement group_id="O32" value="0.07" lower_limit="0.06" upper_limit="0.08"/>
                    <measurement group_id="O33" value="0.02" lower_limit="0.02" upper_limit="0.02"/>
                    <measurement group_id="O34" value="0.03" lower_limit="0.02" upper_limit="1.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.03" lower_limit="0.03" upper_limit="0.13"/>
                    <measurement group_id="O22" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O23" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O24" value="0.07" lower_limit="0.02" upper_limit="0.94"/>
                    <measurement group_id="O25" value="0.02" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O26" value="0.05" lower_limit="0.02" upper_limit="0.08"/>
                    <measurement group_id="O27" value="0.03" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O28" value="0.05" lower_limit="0.03" upper_limit="0.06"/>
                    <measurement group_id="O29" value="0.05" lower_limit="0.03" upper_limit="0.06"/>
                    <measurement group_id="O30" value="0.93" lower_limit="0.02" upper_limit="14.16"/>
                    <measurement group_id="O31" value="0.02" lower_limit="0.02" upper_limit="0.06"/>
                    <measurement group_id="O32" value="0.08" lower_limit="0.02" upper_limit="0.13"/>
                    <measurement group_id="O33" value="0.10" lower_limit="0.07" upper_limit="0.13"/>
                    <measurement group_id="O34" value="0.05" lower_limit="0.02" upper_limit="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.13" lower_limit="0.13" upper_limit="0.13"/>
                    <measurement group_id="O22" value="0.08" lower_limit="0.08" upper_limit="0.08"/>
                    <measurement group_id="O23" value="0.04" lower_limit="0.04" upper_limit="0.04"/>
                    <measurement group_id="O24" value="0.04" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O25" value="0.04" lower_limit="0.02" upper_limit="0.07"/>
                    <measurement group_id="O26" value="0.07" lower_limit="0.07" upper_limit="0.07"/>
                    <measurement group_id="O28" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O30" value="7.07" lower_limit="0.02" upper_limit="14.13"/>
                    <measurement group_id="O31" value="0.10" lower_limit="0.10" upper_limit="0.10"/>
                    <measurement group_id="O33" value="0.02" lower_limit="0.02" upper_limit="0.03"/>
                    <measurement group_id="O34" value="0.03" lower_limit="0.02" upper_limit="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Terminal Half-Life (t ½) of Pembrolizumab Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab t½. t½ was defined as the time required to divide the pembrolizumab plasma concentration by two after reaching pseudo-equilibrium, following a single dose of pembrolizumab. Pembrolizumab t½ was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable t½ samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Terminal Half-Life (t ½) of Pembrolizumab Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab t½. t½ was defined as the time required to divide the pembrolizumab plasma concentration by two after reaching pseudo-equilibrium, following a single dose of pembrolizumab. Pembrolizumab t½ was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable t½ samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="17.2" spread="21.8"/>
                    <measurement group_id="O22" value="12.1" spread="80.3"/>
                    <measurement group_id="O23" value="14.7" spread="32.7"/>
                    <measurement group_id="O24" value="23.5" spread="54.4"/>
                    <measurement group_id="O25" value="11.8" spread="46.4"/>
                    <measurement group_id="O26" value="9.45" spread="61.8"/>
                    <measurement group_id="O27" value="10.9" spread="43.5"/>
                    <measurement group_id="O28" value="17.7" spread="23.1"/>
                    <measurement group_id="O29" value="11.3" spread="22.9"/>
                    <measurement group_id="O30" value="16.1" spread="27.6"/>
                    <measurement group_id="O31" value="13.2" spread="63.6"/>
                    <measurement group_id="O32" value="8.84" spread="189.6"/>
                    <measurement group_id="O33" value="11.2" spread="64.2"/>
                    <measurement group_id="O34" value="19.0" spread="54.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="16.8" spread="30.6"/>
                    <measurement group_id="O22" value="21.1" spread="22.4"/>
                    <measurement group_id="O23" value="10" spread="189.6"/>
                    <measurement group_id="O24" value="18.5" spread="13.4"/>
                    <measurement group_id="O25" value="14.4" spread="42.1"/>
                    <measurement group_id="O26" value="16.0" spread="4.4"/>
                    <measurement group_id="O27" value="15.0" spread="9.17"/>
                    <measurement group_id="O28" value="18.6" spread="38.1"/>
                    <measurement group_id="O29" value="12.7" spread="22.4"/>
                    <measurement group_id="O30" value="15.7" spread="9.65"/>
                    <measurement group_id="O31" value="13.7" spread="18.6"/>
                    <measurement group_id="O32" value="18.9" spread="1.03"/>
                    <measurement group_id="O33" value="17.6" spread="35.9"/>
                    <measurement group_id="O34" value="16.7" spread="55.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="14.0" spread="59.2"/>
                    <measurement group_id="O22" value="10.5" spread="42.1"/>
                    <measurement group_id="O23" value="14.6" spread="39.4"/>
                    <measurement group_id="O24" value="15.2" spread="49.2"/>
                    <measurement group_id="O25" value="15.0" spread="122.9"/>
                    <measurement group_id="O26" value="14.8" spread="5.7"/>
                    <measurement group_id="O27" value="9.45" spread="35.3"/>
                    <measurement group_id="O28" value="20.8" spread="15.4"/>
                    <measurement group_id="O29" value="9.38" spread="6.03"/>
                    <measurement group_id="O30" value="13.3" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="11.3" spread="45.2"/>
                    <measurement group_id="O32" value="8.11" spread="63.8"/>
                    <measurement group_id="O33" value="19.8" spread="11.1"/>
                    <measurement group_id="O34" value="24.9" spread="57.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="1"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="17.7" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="11.1" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="10.5" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="18.0" spread="117.5"/>
                    <measurement group_id="O25" value="34.1" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="14.9" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O28" value="23.3" spread="38.1"/>
                    <measurement group_id="O30" value="22.4" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="15.7" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="6.94" spread="34.8"/>
                    <measurement group_id="O34" value="16.6" spread="109.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of pembrolizumab from time zero to 21 hours after dosing. Pembrolizumab AUC0-21 was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Day 2. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-21 samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to 21 Hours After Dosing (AUC 0-21) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-21. AUC0-21 was defined as the area under the concentration-time curve of pembrolizumab from time zero to 21 hours after dosing. Pembrolizumab AUC0-21 was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-21 samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="587000" spread="36.0"/>
                    <measurement group_id="O22" value="484000" spread="33.8"/>
                    <measurement group_id="O23" value="408000" spread="10.7"/>
                    <measurement group_id="O24" value="664000" spread="15.8"/>
                    <measurement group_id="O25" value="404000" spread="46.4"/>
                    <measurement group_id="O26" value="511000" spread="32.3"/>
                    <measurement group_id="O27" value="535000" spread="31.1"/>
                    <measurement group_id="O28" value="454000" spread="26.0"/>
                    <measurement group_id="O29" value="516000" spread="29.0"/>
                    <measurement group_id="O30" value="664000" spread="9.7"/>
                    <measurement group_id="O31" value="560000" spread="26.5"/>
                    <measurement group_id="O32" value="485000" spread="92.9"/>
                    <measurement group_id="O33" value="599000" spread="34.6"/>
                    <measurement group_id="O34" value="619000" spread="33.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="847000" spread="33.5"/>
                    <measurement group_id="O22" value="672000" spread="45.4"/>
                    <measurement group_id="O23" value="405000" spread="62.8"/>
                    <measurement group_id="O24" value="952000" spread="12.6"/>
                    <measurement group_id="O25" value="579000" spread="46.1"/>
                    <measurement group_id="O26" value="871000" spread="16.5"/>
                    <measurement group_id="O27" value="750000" spread="47.9"/>
                    <measurement group_id="O28" value="739000" spread="48.8"/>
                    <measurement group_id="O29" value="715000" spread="27.9"/>
                    <measurement group_id="O30" value="921000" spread="18.1"/>
                    <measurement group_id="O31" value="825000" spread="21.0"/>
                    <measurement group_id="O32" value="991000" spread="14.5"/>
                    <measurement group_id="O33" value="925000" spread="7.5"/>
                    <measurement group_id="O34" value="825000" spread="32.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="913000" spread="53.8"/>
                    <measurement group_id="O22" value="662000" spread="38.5"/>
                    <measurement group_id="O23" value="622000" spread="2.3"/>
                    <measurement group_id="O24" value="1120000" spread="14.1"/>
                    <measurement group_id="O25" value="633000" spread="59.6"/>
                    <measurement group_id="O26" value="927000" spread="8.1"/>
                    <measurement group_id="O27" value="738000" spread="37.4"/>
                    <measurement group_id="O28" value="903000" spread="50.6"/>
                    <measurement group_id="O29" value="752000" spread="27.4"/>
                    <measurement group_id="O30" value="1220000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="822000" spread="30.2"/>
                    <measurement group_id="O32" value="883000" spread="25.5"/>
                    <measurement group_id="O33" value="967000" spread="6.3"/>
                    <measurement group_id="O34" value="1010000" spread="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="1540000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="490000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="613000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="1050000" spread="38.7"/>
                    <measurement group_id="O25" value="1370000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="1010000" spread="14.7"/>
                    <measurement group_id="O28" value="964000" spread="41.8"/>
                    <measurement group_id="O30" value="1370000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="1460000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="810000" spread="27.7"/>
                    <measurement group_id="O34" value="892000" spread="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-last. AUC0-last was defined as the area under the concentration-time curve of pembrolizumab from time zero to the last quantifiable sample. Pembrolizumab AUC0-last was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-last samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to The Last Quantifiable Sample (AUC 0-last) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-last. AUC0-last was defined as the area under the concentration-time curve of pembrolizumab from time zero to the last quantifiable sample. Pembrolizumab AUC0-last was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-last samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="587000" spread="36.0"/>
                    <measurement group_id="O22" value="356000" spread="79.5"/>
                    <measurement group_id="O23" value="398000" spread="14.3"/>
                    <measurement group_id="O24" value="663000" spread="16.1"/>
                    <measurement group_id="O25" value="410000" spread="44.5"/>
                    <measurement group_id="O26" value="491000" spread="39.9"/>
                    <measurement group_id="O27" value="482000" spread="48.7"/>
                    <measurement group_id="O28" value="414000" spread="35.3"/>
                    <measurement group_id="O29" value="415000" spread="73.7"/>
                    <measurement group_id="O30" value="663000" spread="9.5"/>
                    <measurement group_id="O31" value="549000" spread="18.7"/>
                    <measurement group_id="O32" value="389000" spread="162.2"/>
                    <measurement group_id="O33" value="416000" spread="119.9"/>
                    <measurement group_id="O34" value="624000" spread="34.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="847000" spread="33.4"/>
                    <measurement group_id="O22" value="664000" spread="45.0"/>
                    <measurement group_id="O23" value="321000" spread="125.7"/>
                    <measurement group_id="O24" value="949000" spread="12.7"/>
                    <measurement group_id="O25" value="573000" spread="47.1"/>
                    <measurement group_id="O26" value="985000" spread="34.7"/>
                    <measurement group_id="O27" value="759000" spread="47.9"/>
                    <measurement group_id="O28" value="567000" spread="62.3"/>
                    <measurement group_id="O29" value="766000" spread="18.0"/>
                    <measurement group_id="O30" value="932000" spread="15.8"/>
                    <measurement group_id="O31" value="873000" spread="14.4"/>
                    <measurement group_id="O32" value="958000" spread="9.49"/>
                    <measurement group_id="O33" value="1080000" spread="29.5"/>
                    <measurement group_id="O34" value="635000" spread="78.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="466000" spread="258.9"/>
                    <measurement group_id="O22" value="515000" spread="43.0"/>
                    <measurement group_id="O23" value="554000" spread="14.0"/>
                    <measurement group_id="O24" value="998000" spread="4.5"/>
                    <measurement group_id="O25" value="603000" spread="64.7"/>
                    <measurement group_id="O26" value="938000" spread="6.3"/>
                    <measurement group_id="O27" value="454000" spread="20.5"/>
                    <measurement group_id="O28" value="747000" spread="32.3"/>
                    <measurement group_id="O29" value="604000" spread="26.5"/>
                    <measurement group_id="O30" value="455000" spread="192.8"/>
                    <measurement group_id="O31" value="492000" spread="88.7"/>
                    <measurement group_id="O32" value="264000" spread="343.2"/>
                    <measurement group_id="O33" value="981000" spread="8.1"/>
                    <measurement group_id="O34" value="1080000" spread="33.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="1550000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="490000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="304000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="775000" spread="110.7"/>
                    <measurement group_id="O25" value="98800" spread="96422.3"/>
                    <measurement group_id="O26" value="1120000" spread="72.3"/>
                    <measurement group_id="O28" value="1020000" spread="33.7"/>
                    <measurement group_id="O30" value="1280000" spread="8.0"/>
                    <measurement group_id="O31" value="1410000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="284000" spread="95.5"/>
                    <measurement group_id="O34" value="664000" spread="132.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to Infinity (AUC 0-inf) Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of pembrolizumab from time zero to infinity. Pembrolizumab AUC0-inf was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-inf samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve of Pembrolizumab From Time Zero to Infinity (AUC 0-inf) Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab AUC0-inf. AUC0-inf was defined as the area under the concentration-time curve of pembrolizumab from time zero to infinity. Pembrolizumab AUC0-inf was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable AUC0-inf samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Days•ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="985000" spread="28.0"/>
                    <measurement group_id="O22" value="709000" spread="46.3"/>
                    <measurement group_id="O23" value="647000" spread="11.8"/>
                    <measurement group_id="O24" value="1400000" spread="15.6"/>
                    <measurement group_id="O25" value="582000" spread="65.7"/>
                    <measurement group_id="O26" value="666000" spread="54.4"/>
                    <measurement group_id="O27" value="740000" spread="39.0"/>
                    <measurement group_id="O28" value="786000" spread="37.5"/>
                    <measurement group_id="O29" value="703000" spread="36.0"/>
                    <measurement group_id="O30" value="1090000" spread="23.0"/>
                    <measurement group_id="O31" value="858000" spread="58.4"/>
                    <measurement group_id="O32" value="707000" spread="148.2"/>
                    <measurement group_id="O33" value="855000" spread="55.9"/>
                    <measurement group_id="O34" value="1130000" spread="68.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="1450000" spread="51.4"/>
                    <measurement group_id="O22" value="1280000" spread="47.7"/>
                    <measurement group_id="O23" value="655000" spread="104.6"/>
                    <measurement group_id="O24" value="1700000" spread="21.3"/>
                    <measurement group_id="O25" value="915000" spread="75.1"/>
                    <measurement group_id="O26" value="1410000" spread="19.6"/>
                    <measurement group_id="O27" value="1210000" spread="50.6"/>
                    <measurement group_id="O28" value="1390000" spread="24.5"/>
                    <measurement group_id="O29" value="1030000" spread="19.3"/>
                    <measurement group_id="O30" value="1540000" spread="16.3"/>
                    <measurement group_id="O31" value="1260000" spread="23.3"/>
                    <measurement group_id="O32" value="1820000" spread="13.2"/>
                    <measurement group_id="O33" value="1620000" spread="27.2"/>
                    <measurement group_id="O34" value="1470000" spread="57.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="1440000" spread="94.2"/>
                    <measurement group_id="O22" value="890000" spread="44.1"/>
                    <measurement group_id="O23" value="1000000" spread="21.1"/>
                    <measurement group_id="O24" value="1870000" spread="36.7"/>
                    <measurement group_id="O25" value="1110000" spread="149.0"/>
                    <measurement group_id="O26" value="1450000" spread="7.0"/>
                    <measurement group_id="O27" value="949000" spread="37.0"/>
                    <measurement group_id="O28" value="1770000" spread="41.9"/>
                    <measurement group_id="O29" value="954000" spread="30.3"/>
                    <measurement group_id="O30" value="1870000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="1160000" spread="56.1"/>
                    <measurement group_id="O32" value="1090000" spread="48.3"/>
                    <measurement group_id="O33" value="1820000" spread="0.2"/>
                    <measurement group_id="O34" value="2340000" spread="55.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="1"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="2670000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="667000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="816000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="1980000" spread="118.7"/>
                    <measurement group_id="O25" value="3890000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="1430000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O28" value="2070000" spread="71.7"/>
                    <measurement group_id="O30" value="2710000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="2440000" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="931000" spread="38.4"/>
                    <measurement group_id="O34" value="1730000" spread="112.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apparent Clearance (CL) of Pembrolizumab Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab CL. CL was defined as the volume of plasma from which pembrolizumab is eliminated per unit time following IV pembrolizumab administration. Pembrolizumab CL was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable CL samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Clearance (CL) of Pembrolizumab Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab CL. CL was defined as the volume of plasma from which pembrolizumab is eliminated per unit time following IV pembrolizumab administration. Pembrolizumab CL was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable CL samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>L/Day</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.203" spread="28.0"/>
                    <measurement group_id="O22" value="0.282" spread="46.3"/>
                    <measurement group_id="O23" value="0.309" spread="11.8"/>
                    <measurement group_id="O24" value="0.143" spread="15.6"/>
                    <measurement group_id="O25" value="0.344" spread="65.7"/>
                    <measurement group_id="O26" value="0.301" spread="54.4"/>
                    <measurement group_id="O27" value="0.270" spread="39.0"/>
                    <measurement group_id="O28" value="0.255" spread="37.6"/>
                    <measurement group_id="O29" value="0.284" spread="36.0"/>
                    <measurement group_id="O30" value="0.184" spread="22.9"/>
                    <measurement group_id="O31" value="0.233" spread="58.3"/>
                    <measurement group_id="O32" value="0.283" spread="148.4"/>
                    <measurement group_id="O33" value="0.234" spread="55.9"/>
                    <measurement group_id="O34" value="0.176" spread="68.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.236" spread="33.5"/>
                    <measurement group_id="O22" value="0.298" spread="45.4"/>
                    <measurement group_id="O23" value="0.494" spread="62.7"/>
                    <measurement group_id="O24" value="0.210" spread="12.6"/>
                    <measurement group_id="O25" value="0.346" spread="46.1"/>
                    <measurement group_id="O26" value="0.230" spread="16.5"/>
                    <measurement group_id="O27" value="0.267" spread="47.9"/>
                    <measurement group_id="O28" value="0.271" spread="48.9"/>
                    <measurement group_id="O29" value="0.280" spread="27.9"/>
                    <measurement group_id="O30" value="0.217" spread="18.1"/>
                    <measurement group_id="O31" value="0.242" spread="20.9"/>
                    <measurement group_id="O32" value="0.202" spread="14.5"/>
                    <measurement group_id="O33" value="0.216" spread="7.5"/>
                    <measurement group_id="O34" value="0.242" spread="32.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.219" spread="53.8"/>
                    <measurement group_id="O22" value="0.302" spread="38.5"/>
                    <measurement group_id="O23" value="0.322" spread="2.3"/>
                    <measurement group_id="O24" value="0.178" spread="14.1"/>
                    <measurement group_id="O25" value="0.316" spread="59.5"/>
                    <measurement group_id="O26" value="0.216" spread="8.1"/>
                    <measurement group_id="O27" value="0.271" spread="37.4"/>
                    <measurement group_id="O28" value="0.222" spread="50.7"/>
                    <measurement group_id="O29" value="0.266" spread="27.4"/>
                    <measurement group_id="O30" value="0.164" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="0.243" spread="30.1"/>
                    <measurement group_id="O32" value="0.227" spread="25.5"/>
                    <measurement group_id="O33" value="0.207" spread="6.3"/>
                    <measurement group_id="O34" value="0.199" spread="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="0.130" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="0.408" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="0.326" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="0.190" spread="38.6"/>
                    <measurement group_id="O25" value="0.146" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="0.198" spread="14.7"/>
                    <measurement group_id="O28" value="0.207" spread="41.9"/>
                    <measurement group_id="O30" value="0.147" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="0.137" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="0.247" spread="27.7"/>
                    <measurement group_id="O34" value="0.224" spread="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apparent Volume of Distribution (V) of Pembrolizumab Over Time</title>
        <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered pembrolizumab at the same concentration that it is observed in the blood plasma. Pembrolizumab V was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
        <time_frame>Cycles 1-4: Day 1 pre-dose, at end of pembro infusion (up to 10 minutes), at end of MK-4166 infusion (up to 10 minutes), ~2 hours after start of MK-4166 infusion, Days 2, 3, 8, 15. Each cycle was 21 days. (Up to ~3 months)</time_frame>
        <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable V samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Volume of Distribution (V) of Pembrolizumab Over Time</title>
          <description>Blood samples were collected at pre-specified time points during Cycles 1-4 from MK-4166 plus pembrolizumab combination cohorts only and plasma isolated for analysis of pembrolizumab V. V was defined as the theoretical volume that would be necessary to contain the total amount of administered pembrolizumab at the same concentration that it is observed in the blood plasma. Pembrolizumab V was reported by dose cohort for all participants that received MK-4166 plus pembrolizumab combination therapy. Per protocol, participants receiving MK-4166 monotherapy were excluded from this analysis.</description>
          <population>All allocated participants who received ≥1 dose of pembrolizumab and had evaluable V samples. Per protocol, %GCV values were not reported for cohorts with n&lt;2 participants, and MK-4166 monotherapy dose cohorts were not analyzed. Participants with samples that were hemolyzed or analyzed outside of stability were excluded from the analysis.</population>
          <units>Liters</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="4"/>
                <count group_id="O28" value="3"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="4"/>
                <count group_id="O34" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="4"/>
                    <count group_id="O28" value="3"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="4"/>
                    <count group_id="O34" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="5.03" spread="46.6"/>
                    <measurement group_id="O22" value="4.92" spread="60.7"/>
                    <measurement group_id="O23" value="6.55" spread="21.6"/>
                    <measurement group_id="O24" value="4.85" spread="37.3"/>
                    <measurement group_id="O25" value="5.84" spread="28.1"/>
                    <measurement group_id="O26" value="4.10" spread="6.1"/>
                    <measurement group_id="O27" value="4.25" spread="37.9"/>
                    <measurement group_id="O28" value="6.50" spread="19.5"/>
                    <measurement group_id="O29" value="4.62" spread="23.8"/>
                    <measurement group_id="O30" value="4.27" spread="4.5"/>
                    <measurement group_id="O31" value="4.43" spread="4.2"/>
                    <measurement group_id="O32" value="3.61" spread="30.0"/>
                    <measurement group_id="O33" value="3.78" spread="16.7"/>
                    <measurement group_id="O34" value="4.84" spread="32.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="2"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="5.52" spread="17.2"/>
                    <measurement group_id="O22" value="8.13" spread="53.3"/>
                    <measurement group_id="O23" value="7.76" spread="54.5"/>
                    <measurement group_id="O24" value="5.29" spread="9.3"/>
                    <measurement group_id="O25" value="6.82" spread="32.9"/>
                    <measurement group_id="O26" value="4.92" spread="11.1"/>
                    <measurement group_id="O27" value="5.70" spread="44.1"/>
                    <measurement group_id="O28" value="7.34" spread="92.9"/>
                    <measurement group_id="O29" value="4.88" spread="41.7"/>
                    <measurement group_id="O30" value="4.96" spread="20.0"/>
                    <measurement group_id="O31" value="4.71" spread="23.3"/>
                    <measurement group_id="O32" value="5.36" spread="16.6"/>
                    <measurement group_id="O33" value="5.24" spread="22.5"/>
                    <measurement group_id="O34" value="5.79" spread="38.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="2"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="4.31" spread="10.4"/>
                    <measurement group_id="O22" value="4.40" spread="50.6"/>
                    <measurement group_id="O23" value="6.81" spread="44.4"/>
                    <measurement group_id="O24" value="3.94" spread="39.5"/>
                    <measurement group_id="O25" value="6.73" spread="53.6"/>
                    <measurement group_id="O26" value="4.40" spread="7.7"/>
                    <measurement group_id="O27" value="3.62" spread="55.0"/>
                    <measurement group_id="O28" value="6.51" spread="62.6"/>
                    <measurement group_id="O29" value="3.63" spread="20.5"/>
                    <measurement group_id="O30" value="3.24" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="4.01" spread="15.4"/>
                    <measurement group_id="O32" value="2.64" spread="33.9"/>
                    <measurement group_id="O33" value="5.66" spread="14.9"/>
                    <measurement group_id="O34" value="7.09" spread="73.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="1"/>
                    <count group_id="O22" value="1"/>
                    <count group_id="O23" value="1"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="1"/>
                    <count group_id="O26" value="1"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="1"/>
                    <count group_id="O31" value="1"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O21" value="3.10" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O22" value="6.37" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O23" value="4.92" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O24" value="4.78" spread="54.9"/>
                    <measurement group_id="O25" value="7.05" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O26" value="4.47" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O28" value="6.85" spread="6.4"/>
                    <measurement group_id="O30" value="4.31" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O31" value="3.17" spread="NA">NA = %GCV values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O33" value="2.46" spread="7.2"/>
                    <measurement group_id="O34" value="5.48" spread="44.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein (GITR) Receptor Availability Following MK-4166 Administration</title>
        <description>GITR protein receptor is internalized upon binding by MK-4166. To evaluate GITR target engagement, a GITR receptor availability assay was developed to assess the availability of cell surface GITR following administration of MK-4166. GITR was detected on CD4+CD25+ and CD4+CD95+ T-cell sub-populations in peripheral blood using flow cytometry. GITR receptor availability on representative CD4+ CD25+ T cell subsets following MK-4166 administration was reported over time for each dose cohort.</description>
        <time_frame>Cycle 1 Day 1: at end of infusion (up to 10 minutes), 2 hours post-infusion, Cycle 1 Days 2, 3, 5, 8, 15, Cycle 2 Day 1 pre-dose. Each cycle was 21 days.</time_frame>
        <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable flow cytometry data.</population>
        <group_list>
          <group group_id="O1">
            <title>MK-4166 0.0015 mg</title>
            <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O2">
            <title>MK-4166 0.0045 mg</title>
            <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O3">
            <title>MK-4166 0.014 mg</title>
            <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O4">
            <title>MK-4166 0.04 mg</title>
            <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O5">
            <title>MK-4166 0.12 mg</title>
            <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O6">
            <title>MK-4166 0.37 mg</title>
            <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O7">
            <title>MK-4166 1.1 mg</title>
            <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O8">
            <title>MK-4166 3.3 mg</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O9">
            <title>MK-4166 10 mg</title>
            <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O10">
            <title>MK-4166 30 mg</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O11">
            <title>MK-4166 42 mg</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O12">
            <title>MK-4166 59 mg</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O13">
            <title>MK-4166 82 mg</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O14">
            <title>MK-4166 120 mg</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O15">
            <title>MK-4166 170 mg</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O16">
            <title>MK-4166 240 mg</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O17">
            <title>MK-4166 340 mg</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O18">
            <title>MK-4166 480 mg</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O19">
            <title>MK-4166 670 mg</title>
            <description>Participant received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O20">
            <title>MK-4166 900 mg</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
          </group>
          <group group_id="O21">
            <title>MK-4166 1.1 mg + Pembro</title>
            <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O22">
            <title>MK-4166 3.3 mg + Pembro</title>
            <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O23">
            <title>MK-4166 10 mg + Pembro</title>
            <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O24">
            <title>MK-4166 30 mg + Pembro</title>
            <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O25">
            <title>MK-4166 42 mg + Pembro</title>
            <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O26">
            <title>MK-4166 59 mg + Pembro</title>
            <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O27">
            <title>MK-4166 82 mg + Pembro</title>
            <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O28">
            <title>MK-4166 120 mg + Pembro</title>
            <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O29">
            <title>MK-4166 170 mg + Pembro</title>
            <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O30">
            <title>MK-4166 240 mg + Pembro</title>
            <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O31">
            <title>MK-4166 340 mg + Pembro</title>
            <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O32">
            <title>MK-4166 480 mg + Pembro</title>
            <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O33">
            <title>MK-4166 670 mg + Pembro</title>
            <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
          <group group_id="O34">
            <title>MK-4166 900 mg + Pembro</title>
            <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
          </group>
        </group_list>
        <measure>
          <title>Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein (GITR) Receptor Availability Following MK-4166 Administration</title>
          <description>GITR protein receptor is internalized upon binding by MK-4166. To evaluate GITR target engagement, a GITR receptor availability assay was developed to assess the availability of cell surface GITR following administration of MK-4166. GITR was detected on CD4+CD25+ and CD4+CD95+ T-cell sub-populations in peripheral blood using flow cytometry. GITR receptor availability on representative CD4+ CD25+ T cell subsets following MK-4166 administration was reported over time for each dose cohort.</description>
          <population>All allocated participants who received at least 1 dose of MK-4166 and had evaluable flow cytometry data.</population>
          <units>Percentage GITR receptor availability</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="5"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="3"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="5"/>
                <count group_id="O17" value="3"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="1"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="3"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="3"/>
                <count group_id="O25" value="3"/>
                <count group_id="O26" value="3"/>
                <count group_id="O27" value="3"/>
                <count group_id="O28" value="2"/>
                <count group_id="O29" value="3"/>
                <count group_id="O30" value="3"/>
                <count group_id="O31" value="3"/>
                <count group_id="O32" value="3"/>
                <count group_id="O33" value="3"/>
                <count group_id="O34" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1:Day 1; End of Infusion</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="5"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="4"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="3"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="0"/>
                    <count group_id="O29" value="3"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="3"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="52.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="92.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="51.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="8.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="4.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="3.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="26.3" spread="32.0"/>
                    <measurement group_id="O11" value="10.8" spread="9.9"/>
                    <measurement group_id="O12" value="9.1" spread="3.2"/>
                    <measurement group_id="O13" value="4.2" spread="2.7"/>
                    <measurement group_id="O14" value="41.9" spread="4.7"/>
                    <measurement group_id="O15" value="7.4" spread="5.9"/>
                    <measurement group_id="O16" value="9.5" spread="6.5"/>
                    <measurement group_id="O17" value="13.9" spread="3.4"/>
                    <measurement group_id="O18" value="15.0" spread="9.8"/>
                    <measurement group_id="O19" value="26.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="14.4" spread="15.1"/>
                    <measurement group_id="O21" value="6.9" spread="3.2"/>
                    <measurement group_id="O22" value="4.2" spread="1.5"/>
                    <measurement group_id="O23" value="7.3" spread="3.6"/>
                    <measurement group_id="O24" value="7.6" spread="6.8"/>
                    <measurement group_id="O25" value="7.0" spread="2.6"/>
                    <measurement group_id="O26" value="4.6" spread="2.3"/>
                    <measurement group_id="O27" value="19.9" spread="15.4"/>
                    <measurement group_id="O29" value="46.5" spread="54.5"/>
                    <measurement group_id="O30" value="8.8" spread="5.3"/>
                    <measurement group_id="O31" value="26.8" spread="18.4"/>
                    <measurement group_id="O32" value="28.4" spread="28.3"/>
                    <measurement group_id="O33" value="10.5" spread="8.9"/>
                    <measurement group_id="O34" value="13.3" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1:Day 1; 2 hours Post Infusion</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="1"/>
                    <count group_id="O25" value="0"/>
                    <count group_id="O26" value="0"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="0"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="0"/>
                    <count group_id="O31" value="0"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="0"/>
                    <count group_id="O34" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="63.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="91.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="42.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="17.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="2.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="1.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="0.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O12" value="6.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O21" value="4.9" spread="2.5"/>
                    <measurement group_id="O22" value="3.0" spread="2.1"/>
                    <measurement group_id="O23" value="8.1" spread="4.8"/>
                    <measurement group_id="O24" value="9.1" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1: Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="5"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="5"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="2"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="2"/>
                    <count group_id="O28" value="0"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="3"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="59.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="96.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="55.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="9.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="2.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="3.3" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="46.2" spread="86.4"/>
                    <measurement group_id="O11" value="15.2" spread="3.0"/>
                    <measurement group_id="O12" value="4.8" spread="1.0"/>
                    <measurement group_id="O13" value="17.4" spread="24.6"/>
                    <measurement group_id="O14" value="30.4" spread="34.6"/>
                    <measurement group_id="O15" value="5.8" spread="5.2"/>
                    <measurement group_id="O16" value="14.7" spread="7.1"/>
                    <measurement group_id="O17" value="12.0" spread="8.9"/>
                    <measurement group_id="O18" value="6.7" spread="2.6"/>
                    <measurement group_id="O19" value="82.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="20.0" spread="10.7"/>
                    <measurement group_id="O21" value="6.1" spread="3.1"/>
                    <measurement group_id="O22" value="2.4" spread="0.3"/>
                    <measurement group_id="O23" value="7.3" spread="4.0"/>
                    <measurement group_id="O24" value="7.1" spread="1.2"/>
                    <measurement group_id="O25" value="6.5" spread="0.2"/>
                    <measurement group_id="O26" value="7.4" spread="2.2"/>
                    <measurement group_id="O27" value="6.7" spread="4.6"/>
                    <measurement group_id="O29" value="5.9" spread="0.9"/>
                    <measurement group_id="O30" value="11.4" spread="4.2"/>
                    <measurement group_id="O31" value="23.0" spread="3.4"/>
                    <measurement group_id="O32" value="26.0" spread="32.2"/>
                    <measurement group_id="O33" value="13.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="15.6" spread="20.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1: Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="4"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="4"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="1"/>
                    <count group_id="O25" value="0"/>
                    <count group_id="O26" value="0"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="0"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="0"/>
                    <count group_id="O31" value="0"/>
                    <count group_id="O32" value="1"/>
                    <count group_id="O33" value="0"/>
                    <count group_id="O34" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.1" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="108.3" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="85.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="72.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="5.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="2.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="0.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="50.0" spread="70.1"/>
                    <measurement group_id="O12" value="4.3" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O21" value="7.2" spread="3.5"/>
                    <measurement group_id="O22" value="2.4" spread="1.3"/>
                    <measurement group_id="O23" value="3.9" spread="1.3"/>
                    <measurement group_id="O24" value="1.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O32" value="9.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1: Day 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                    <count group_id="O13" value="0"/>
                    <count group_id="O14" value="0"/>
                    <count group_id="O15" value="0"/>
                    <count group_id="O16" value="0"/>
                    <count group_id="O17" value="0"/>
                    <count group_id="O18" value="0"/>
                    <count group_id="O19" value="0"/>
                    <count group_id="O20" value="0"/>
                    <count group_id="O21" value="0"/>
                    <count group_id="O22" value="0"/>
                    <count group_id="O23" value="0"/>
                    <count group_id="O24" value="0"/>
                    <count group_id="O25" value="0"/>
                    <count group_id="O26" value="0"/>
                    <count group_id="O27" value="0"/>
                    <count group_id="O28" value="0"/>
                    <count group_id="O29" value="0"/>
                    <count group_id="O30" value="0"/>
                    <count group_id="O31" value="0"/>
                    <count group_id="O32" value="0"/>
                    <count group_id="O33" value="0"/>
                    <count group_id="O34" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="107.1" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="111.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="83.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="8.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="1.7" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="4.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1: Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="5"/>
                    <count group_id="O11" value="3"/>
                    <count group_id="O12" value="3"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="2"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="4"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="3"/>
                    <count group_id="O28" value="1"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="2"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="1"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O3" value="103.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="114.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="89.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="15.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="8.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="148.6" spread="281.6"/>
                    <measurement group_id="O11" value="5.8" spread="4.3"/>
                    <measurement group_id="O12" value="6.3" spread="5.1"/>
                    <measurement group_id="O13" value="10.0" spread="8.3"/>
                    <measurement group_id="O14" value="10.2" spread="3.6"/>
                    <measurement group_id="O15" value="2.2" spread="0.4"/>
                    <measurement group_id="O16" value="16.0" spread="9.4"/>
                    <measurement group_id="O17" value="19.3" spread="15.3"/>
                    <measurement group_id="O18" value="22.5" spread="12.6"/>
                    <measurement group_id="O19" value="82.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="15.5" spread="11.3"/>
                    <measurement group_id="O21" value="10.2" spread="8.9"/>
                    <measurement group_id="O22" value="2.9" spread="2.3"/>
                    <measurement group_id="O23" value="5.4" spread="4.6"/>
                    <measurement group_id="O24" value="12.8" spread="7.1"/>
                    <measurement group_id="O25" value="3.8" spread="1.8"/>
                    <measurement group_id="O26" value="6.0" spread="4.9"/>
                    <measurement group_id="O27" value="9.3" spread="4.9"/>
                    <measurement group_id="O28" value="8.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O29" value="4.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="11.8" spread="7.0"/>
                    <measurement group_id="O31" value="12.0" spread="5.6"/>
                    <measurement group_id="O32" value="25.3" spread="3.0"/>
                    <measurement group_id="O33" value="8.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O34" value="11.3" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1: Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="5"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="1"/>
                    <count group_id="O13" value="2"/>
                    <count group_id="O14" value="1"/>
                    <count group_id="O15" value="3"/>
                    <count group_id="O16" value="3"/>
                    <count group_id="O17" value="3"/>
                    <count group_id="O18" value="2"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="3"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="3"/>
                    <count group_id="O27" value="1"/>
                    <count group_id="O28" value="1"/>
                    <count group_id="O29" value="1"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="123.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="122.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="94.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="74.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O7" value="71.4" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="71.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="169.3" spread="301.5"/>
                    <measurement group_id="O11" value="2.2" spread="1.6"/>
                    <measurement group_id="O12" value="4.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O13" value="40.9" spread="28.1"/>
                    <measurement group_id="O14" value="6.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O15" value="8.9" spread="13.8"/>
                    <measurement group_id="O16" value="15.2" spread="15.9"/>
                    <measurement group_id="O17" value="8.1" spread="6.7"/>
                    <measurement group_id="O18" value="4.8" spread="2.7"/>
                    <measurement group_id="O19" value="65.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="15.5" spread="5.6"/>
                    <measurement group_id="O21" value="39.9" spread="49.1"/>
                    <measurement group_id="O22" value="4.8" spread="1.8"/>
                    <measurement group_id="O23" value="8.8" spread="9.2"/>
                    <measurement group_id="O24" value="11.4" spread="8.7"/>
                    <measurement group_id="O25" value="5.0" spread="4.3"/>
                    <measurement group_id="O26" value="9.1" spread="4.8"/>
                    <measurement group_id="O27" value="28.6" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O28" value="12.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O29" value="22.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O30" value="3.8" spread="1.5"/>
                    <measurement group_id="O31" value="40.8" spread="54.4"/>
                    <measurement group_id="O32" value="22.5" spread="8.7"/>
                    <measurement group_id="O33" value="21.9" spread="17.6"/>
                    <measurement group_id="O34" value="13.0" spread="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2: Day 1; Pre-dose</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="2"/>
                    <count group_id="O12" value="2"/>
                    <count group_id="O13" value="3"/>
                    <count group_id="O14" value="3"/>
                    <count group_id="O15" value="2"/>
                    <count group_id="O16" value="3"/>
                    <count group_id="O17" value="2"/>
                    <count group_id="O18" value="3"/>
                    <count group_id="O19" value="1"/>
                    <count group_id="O20" value="3"/>
                    <count group_id="O21" value="3"/>
                    <count group_id="O22" value="3"/>
                    <count group_id="O23" value="3"/>
                    <count group_id="O24" value="2"/>
                    <count group_id="O25" value="2"/>
                    <count group_id="O26" value="1"/>
                    <count group_id="O27" value="1"/>
                    <count group_id="O28" value="2"/>
                    <count group_id="O29" value="2"/>
                    <count group_id="O30" value="3"/>
                    <count group_id="O31" value="3"/>
                    <count group_id="O32" value="2"/>
                    <count group_id="O33" value="2"/>
                    <count group_id="O34" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O4" value="114.9" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O5" value="92.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O6" value="80.3" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O9" value="84.8" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O10" value="49.3" spread="84.6"/>
                    <measurement group_id="O11" value="57.1" spread="52.9"/>
                    <measurement group_id="O12" value="67.4" spread="91.5"/>
                    <measurement group_id="O13" value="7.6" spread="5.5"/>
                    <measurement group_id="O14" value="7.8" spread="3.8"/>
                    <measurement group_id="O15" value="29.3" spread="28.1"/>
                    <measurement group_id="O16" value="44.8" spread="62.4"/>
                    <measurement group_id="O17" value="17.7" spread="5.7"/>
                    <measurement group_id="O18" value="39.0" spread="50.0"/>
                    <measurement group_id="O19" value="77.0" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O20" value="7.0" spread="3.6"/>
                    <measurement group_id="O21" value="109.9" spread="37.2"/>
                    <measurement group_id="O22" value="74.1" spread="36.4"/>
                    <measurement group_id="O23" value="70.0" spread="51.8"/>
                    <measurement group_id="O24" value="11.7" spread="7.9"/>
                    <measurement group_id="O25" value="12.6" spread="6.9"/>
                    <measurement group_id="O26" value="13.5" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O27" value="51.2" spread="NA">NA = SD values were not reported when n&lt;2.</measurement>
                    <measurement group_id="O28" value="8.3" spread="5.8"/>
                    <measurement group_id="O29" value="7.3" spread="9.3"/>
                    <measurement group_id="O30" value="13.0" spread="12.5"/>
                    <measurement group_id="O31" value="55.5" spread="43.2"/>
                    <measurement group_id="O32" value="8.0" spread="7.8"/>
                    <measurement group_id="O33" value="27.4" spread="19.2"/>
                    <measurement group_id="O34" value="9.2" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to approximately 61 months (through final cut-off date of 31-Jul-2019)</time_frame>
      <desc>All-Cause Mortality table includes all allocated participants.&#xD;
Serious and Other adverse events (AEs) include all allocated participants who received ≥1 dose of study drug. Per protocol, disease progression of cancer on study not considered an AE unless considered related to study drug. Thus, MedDRA preferred terms &quot;Neoplasm progression&quot;, &quot;Malignant neoplasm progression&quot; and &quot;Disease progression&quot; not related to study drug are excluded as AEs. Data reported by treatment arm and by dose cohort</desc>
      <group_list>
        <group group_id="E1">
          <title>MK-4166</title>
          <description>All participants that received MK-4166 IV on Day 1 of each 21-day cycle, for up to 4 cycles (according to assigned dose).</description>
        </group>
        <group group_id="E2">
          <title>MK-4166 + Pembro</title>
          <description>All participants that received MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles (according to assigned dose) plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles (according to assigned doses).</description>
        </group>
        <group group_id="E3">
          <title>MK-4166 0.0015 mg</title>
          <description>Participant received 0.0015 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E4">
          <title>MK-4166 0.0045 mg</title>
          <description>Participant received 0.0045 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E5">
          <title>MK-4166 0.014 mg</title>
          <description>Participant received 0.014 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E6">
          <title>MK-4166 0.04 mg</title>
          <description>Participant received 0.04 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E7">
          <title>MK-4166 0.12 mg</title>
          <description>Participant received 0.12 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E8">
          <title>MK-4166 0.37 mg</title>
          <description>Participant received 0.37 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E9">
          <title>MK-4166 1.1 mg</title>
          <description>Participant received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E10">
          <title>MK-4166 3.3 mg</title>
          <description>Participant received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E11">
          <title>MK-4166 10 mg</title>
          <description>Participant received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E12">
          <title>MK-4166 30 mg</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E13">
          <title>MK-4166 42 mg</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E14">
          <title>MK-4166 59 mg</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E15">
          <title>MK-4166 82 mg</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E16">
          <title>MK-4166 120 mg</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E17">
          <title>MK-4166 170 mg</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E18">
          <title>MK-4166 240 mg</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E19">
          <title>MK-4166 340 mg</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E20">
          <title>MK-4166 480 mg</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E21">
          <title>MK-4166 670 mg</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E22">
          <title>MK-4166 900 mg</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles.</description>
        </group>
        <group group_id="E23">
          <title>MK-4166 1.1 mg + Pembro</title>
          <description>Participants received 1.1 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E24">
          <title>MK-4166 3.3 mg + Pembro</title>
          <description>Participants received 3.3 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E25">
          <title>MK-4166 10 mg + Pembro</title>
          <description>Participants received 10 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E26">
          <title>MK-4166 30 mg + Pembro</title>
          <description>Participants received 30 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E27">
          <title>MK-4166 42 mg + Pembro</title>
          <description>Participants received 42 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E28">
          <title>MK-4166 59 mg + Pembro</title>
          <description>Participants received 59 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E29">
          <title>MK-4166 82 mg + Pembro</title>
          <description>Participants received 82 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E30">
          <title>MK-4166 120 mg + Pembro</title>
          <description>Participants received 120 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E31">
          <title>MK-4166 170 mg + Pembro</title>
          <description>Participants received 170 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E32">
          <title>MK-4166 240 mg + Pembro</title>
          <description>Participants received 240 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E33">
          <title>MK-4166 340 mg + Pembro</title>
          <description>Participants received 340 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E34">
          <title>MK-4166 480 mg + Pembro</title>
          <description>Participants received 480 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E35">
          <title>MK-4166 670 mg + Pembro</title>
          <description>Participants received 670 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
        <group group_id="E36">
          <title>MK-4166 900 mg + Pembro</title>
          <description>Participants received 900 mg MK-4166 IV on Day 1 of each 21-day cycle for up to 4 cycles plus pembrolizumab 200 mg IV on Day 1 of each 21-day cycle for up to 35 cycles.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 22.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="66"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E29" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E36" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E28" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E36" subjects_affected="7" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oesophageal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Tumour necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 22.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E22" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E23" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E26" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E27" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E28" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E29" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E30" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E31" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E32" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E33" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E34" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E35" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E36" subjects_affected="22" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypophysitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Conjunctival hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="48"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="3" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="48"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="15" subjects_affected="9" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="5" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="48"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E12" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="6" subjects_affected="6" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E2" events="18" subjects_affected="13" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="6" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Angina bullosa haemorrhagica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia teeth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Catheter site scar</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Early satiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="48"/>
                <counts group_id="E2" events="42" subjects_affected="37" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E24" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E25" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E26" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E29" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E31" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="17" subjects_affected="14" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Feeling hot</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Contrast media reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="6" subjects_affected="6" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Herpes ophthalmic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Infusion related reaction</sub_title>
                <counts group_id="E1" events="13" subjects_affected="9" subjects_at_risk="48"/>
                <counts group_id="E2" events="27" subjects_affected="22" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E33" events="4" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E36" events="13" subjects_affected="10" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Neutrophil count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Amylase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="48"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="6" subjects_affected="5" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="7" subjects_affected="6" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Tendon pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Tumour pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dysmetria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Motor dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Trigeminal nerve disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Sinus headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dyspareunia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vulvovaginal rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="48"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="48"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nasal crusting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Respiratory symptom</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Throat tightness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis acneiform</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hirsutism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Palmar erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="48"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E22" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="9" subjects_affected="7" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="7" subjects_affected="5" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E33" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Skin mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vitiligo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Menopause</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="4" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E27" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E28" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E29" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E30" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E31" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E32" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E33" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E34" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E35" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E36" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

